Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ASTROTECH CONFIRMS RECEIPT OF UNSOLICTED NON-BINDING ACQUISITION PROPOSAL
Astrotech Corporation (ASTC) : 14.20
AUSTIN, Texas, (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) announced that it has received an unsolicited, non-binding proposal from BML Investment Partners, L.P. (“BML”) to acquire all of the outstanding shares of common stock of the Company for cash consideration of $17.25 per share. The non-binding proposal states that BML holds 13% of the Company’s outstanding shares. The non-binding proposal is not subject to a financing condition but is subject to limited confirmatory due diligence and is based on the Company having at least $35 million of cash and cash equivalents as of the potential closing date of the proposed acquisition, net of any tail and closing costs, and not having issued any shares pursuant to its at-the-market offering agreement dated June 16, 2023 (the “ATM Agreement”). Effective June 27, 2023, the Company terminated the ATM Agreement in accordance with its terms.
Consistent with its fiduciary duties, the Company’s board of directors will evaluate the non-binding proposal to determine the course of action that it believes is in the best interest of the Company and all Astrotech stockholders and respond appropriately. The Astrotech stockholders do not need to take any action at this time.
About Astrotech Corporation
Astrotech (Nasdaq: ASTC) is a mass spectrometry company that launches, manages, and commercializes scalable companies based on its innovative core technology through its wholly-owned subsidiaries. 1st Detect develops, manufactures, and sells trace detectors for use in the security and detection market. AgLAB is developing chemical analyzers for use in the agriculture market. BreathTech is developing a breath analysis tool to provide early detection of lung diseases. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com.
Total Cash (mrq) 44.15M
Total Cash Per Share (mrq) 26.21
Total Debt (mrq) 576k
Book Value Per Share (mrq) 27.75
https://www.otcmarkets.com/filing/conv_pdf?id=16756014&guid=T-D-kK4N_tXrcLh
Jun 01, 2023 11.36 11.78 10.89 11.40 11.40 35,600
May 01, 2023 10.34 11.95 10.04 11.50 11.50 115,000
Apr 01, 2023 10.65 11.00 10.14 10.40 10.40 45,400
Mar 01, 2023 12.87 13.01 10.10 10.66 10.66 96,900
Feb 01, 2023 12.10 14.07 11.53 12.95 12.95 443,400
Jan 01, 2023 9.99 12.34 9.99 12.09 12.09 125,800
Dec 01, 2022 9.90 11.82 9.28 9.99 9.99 547,217
Nov 01, 2022 12.00 13.50 9.30 10.20 10.20 301,281
Oct 01, 2022 13.20 13.80 10.20 12.30 12.30 183,265
Sep 01, 2022 13.80 14.40 12.30 13.20 13.20 204,439
Aug 01, 2022 13.80 16.20 12.30 13.80 13.80 263,144
Jul 01, 2022 12.60 14.70 12.60 13.80 13.80 63,550
Jun 01, 2022 16.50 17.10 12.60 12.90 12.90 107,050
May 01, 2022 15.90 16.80 14.40 16.50 16.50 98,090
Apr 01, 2022 21.60 22.20 15.90 16.20 16.20 121,183
Mar 01, 2022 21.60 23.10 19.80 21.60 21.60 192,625
Feb 01, 2022 19.20 22.20 18.00 21.30 21.30 249,151
Jan 01, 2022 20.40 23.10 18.00 19.50 19.50 234,297
Dec 01, 2021 24.30 24.60 19.50 20.40 20.40 371,402
Nov 01, 2021 31.20 33.00 22.80 24.00 24.00 522,731
Oct 01, 2021 31.50 34.50 29.10 30.90 30.90 726,944
Sep 01, 2021 33.30 33.90 28.80 31.50 31.50 391,866
Aug 01, 2021 34.50 36.30 28.20 33.30 33.30 1,657,386
Jul 01, 2021 41.40 42.00 30.00 32.40 32.40 963,596
Jun 01, 2021 35.40 39.90 33.60 39.90 39.90 1,113,366
May 01, 2021 36.90 37.20 30.90 35.10 35.10 998,583
Apr 01, 2021 66.60 89.40 32.10 36.90 36.90 6,113,055
Mar 01, 2021 70.50 76.20 42.90 65.70 65.70 1,323,382
Feb 01, 2021 59.40 124.20 59.40 65.70 65.70 2,390,276
ASTROTECH CONFIRMS RECEIPT OF UNSOLICTED NON-BINDING ACQUISITION PROPOSAL
Astrotech Corporation (ASTC) : 14.20
AUSTIN, Texas, (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) announced that it has received an unsolicited, non-binding proposal from BML Investment Partners, L.P. (“BML”) to acquire all of the outstanding shares of common stock of the Company for cash consideration of $17.25 per share. The non-binding proposal states that BML holds 13% of the Company’s outstanding shares. The non-binding proposal is not subject to a financing condition but is subject to limited confirmatory due diligence and is based on the Company having at least $35 million of cash and cash equivalents as of the potential closing date of the proposed acquisition, net of any tail and closing costs, and not having issued any shares pursuant to its at-the-market offering agreement dated June 16, 2023 (the “ATM Agreement”). Effective June 27, 2023, the Company terminated the ATM Agreement in accordance with its terms.
Consistent with its fiduciary duties, the Company’s board of directors will evaluate the non-binding proposal to determine the course of action that it believes is in the best interest of the Company and all Astrotech stockholders and respond appropriately. The Astrotech stockholders do not need to take any action at this time.
About Astrotech Corporation
Astrotech (Nasdaq: ASTC) is a mass spectrometry company that launches, manages, and commercializes scalable companies based on its innovative core technology through its wholly-owned subsidiaries. 1st Detect develops, manufactures, and sells trace detectors for use in the security and detection market. AgLAB is developing chemical analyzers for use in the agriculture market. BreathTech is developing a breath analysis tool to provide early detection of lung diseases. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com.
Total Cash (mrq) 44.15M
Total Cash Per Share (mrq) 26.21
Total Debt (mrq) 576k
Book Value Per Share (mrq) 27.75
https://www.otcmarkets.com/filing/conv_pdf?id=16756014&guid=T-D-kK4N_tXrcLh
Jun 01, 2023 11.36 11.78 10.89 11.40 11.40 35,600
May 01, 2023 10.34 11.95 10.04 11.50 11.50 115,000
Apr 01, 2023 10.65 11.00 10.14 10.40 10.40 45,400
Mar 01, 2023 12.87 13.01 10.10 10.66 10.66 96,900
Feb 01, 2023 12.10 14.07 11.53 12.95 12.95 443,400
Jan 01, 2023 9.99 12.34 9.99 12.09 12.09 125,800
Dec 01, 2022 9.90 11.82 9.28 9.99 9.99 547,217
Nov 01, 2022 12.00 13.50 9.30 10.20 10.20 301,281
Oct 01, 2022 13.20 13.80 10.20 12.30 12.30 183,265
Sep 01, 2022 13.80 14.40 12.30 13.20 13.20 204,439
Aug 01, 2022 13.80 16.20 12.30 13.80 13.80 263,144
Jul 01, 2022 12.60 14.70 12.60 13.80 13.80 63,550
Jun 01, 2022 16.50 17.10 12.60 12.90 12.90 107,050
May 01, 2022 15.90 16.80 14.40 16.50 16.50 98,090
Apr 01, 2022 21.60 22.20 15.90 16.20 16.20 121,183
Mar 01, 2022 21.60 23.10 19.80 21.60 21.60 192,625
Feb 01, 2022 19.20 22.20 18.00 21.30 21.30 249,151
Jan 01, 2022 20.40 23.10 18.00 19.50 19.50 234,297
Dec 01, 2021 24.30 24.60 19.50 20.40 20.40 371,402
Nov 01, 2021 31.20 33.00 22.80 24.00 24.00 522,731
Oct 01, 2021 31.50 34.50 29.10 30.90 30.90 726,944
Sep 01, 2021 33.30 33.90 28.80 31.50 31.50 391,866
Aug 01, 2021 34.50 36.30 28.20 33.30 33.30 1,657,386
Jul 01, 2021 41.40 42.00 30.00 32.40 32.40 963,596
Jun 01, 2021 35.40 39.90 33.60 39.90 39.90 1,113,366
May 01, 2021 36.90 37.20 30.90 35.10 35.10 998,583
Apr 01, 2021 66.60 89.40 32.10 36.90 36.90 6,113,055
Mar 01, 2021 70.50 76.20 42.90 65.70 65.70 1,323,382
Feb 01, 2021 59.40 124.20 59.40 65.70 65.70 2,390,276
It will be a story like with QNCX
Quince, confirmed the takeover bid in a brief press statement. The offer valued Quince at $1.6 per share, for a total of $58.8 million.
The stock went to 1.93…
Apr 10, 2023 1.6100 1.6400 1.4300 1.5400 1.5400 1,479,500
Apr 03, 2023 1.6100 1.9300 1.5700 1.6400 1.6400 2,136,100
Mar 27, 2023 1.4800 1.5800 1.4500 1.5600 1.5600 2,305,400
Mar 20, 2023 0.8380 1.5300 0.8010 1.4900 1.4900 57,274,000
Mar 13, 2023 0.9500 0.9600 0.7900 0.8300 0.8300 1,108,000
Here we have an offer of $17.5 but they have almost no debt and more than 44 million cash.
Total Cash (mrq) 44.15M
Total Cash Per Share (mrq) 26.21
Total Debt (mrq) 576k
Shares Outstanding 1.68M
Float 1.28M
Total assets: 56.22 M
So they will say with cash alone more than $25/share, the price is way too low and they want at least 22 – 27...
It will be a story like with QNCX
Quince, confirmed the takeover bid in a brief press statement. The offer valued Quince at $1.6 per share, for a total of $58.8 million.
The stock went to 1.93…
Apr 10, 2023 1.6100 1.6400 1.4300 1.5400 1.5400 1,479,500
Apr 03, 2023 1.6100 1.9300 1.5700 1.6400 1.6400 2,136,100
Mar 27, 2023 1.4800 1.5800 1.4500 1.5600 1.5600 2,305,400
Mar 20, 2023 0.8380 1.5300 0.8010 1.4900 1.4900 57,274,000
Mar 13, 2023 0.9500 0.9600 0.7900 0.8300 0.8300 1,108,000
Here we have an offer of $17.5 but they have almost no debt and more than 44 million cash.
Total Cash (mrq) 44.15M
Total Cash Per Share (mrq) 26.21
Total Debt (mrq) 576k
Shares Outstanding 1.68M
Float 1.28M
Total assets: 56.22 M
So they will say with cash alone more than $25/share, the price is way too low and they want at least 22 – 27...
ASTROTECH CONFIRMS RECEIPT OF UNSOLICTED NON-BINDING ACQUISITION PROPOSAL
Astrotech Corporation
Tue, June 27, 2023 at 11:34 PM GMT+2
AUSTIN, Texas, June 27, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) announced today that it has received an unsolicited, non-binding proposal from BML Investment Partners, L.P. (“BML”) to acquire all of the outstanding shares of common stock of the Company for cash consideration of $17.25 per share. The non-binding proposal states that BML holds 13% of the Company’s outstanding shares. The non-binding proposal is not subject to a financing condition but is subject to limited confirmatory due diligence and is based on the Company having at least $35 million of cash and cash equivalents as of the potential closing date of the proposed acquisition, net of any tail and closing costs, and not having issued any shares pursuant to its at-the-market offering agreement dated June 16, 2023 (the “ATM Agreement”). Effective June 27, 2023, the Company terminated the ATM Agreement in accordance with its terms.
Consistent with its fiduciary duties, the Company’s board of directors will evaluate the non-binding proposal to determine the course of action that it believes is in the best interest of the Company and all Astrotech stockholders and respond appropriately. The Astrotech stockholders do not need to take any action at this time.
About Astrotech Corporation
Astrotech (Nasdaq: ASTC) is a mass spectrometry company that launches, manages, and commercializes scalable companies based on its innovative core technology through its wholly-owned subsidiaries. 1st Detect develops, manufactures, and sells trace detectors for use in the security and detection market. AgLAB is developing chemical analyzers for use in the agriculture market. BreathTech is developing a breath analysis tool to provide early detection of lung diseases. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com.
ASTROTECH CONFIRMS RECEIPT OF UNSOLICTED NON-BINDING ACQUISITION PROPOSAL
Astrotech Corporation
Tue, June 27, 2023 at 11:34 PM GMT+2
AUSTIN, Texas, June 27, 2023 (GLOBE NEWSWIRE) -- Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) announced today that it has received an unsolicited, non-binding proposal from BML Investment Partners, L.P. (“BML”) to acquire all of the outstanding shares of common stock of the Company for cash consideration of $17.25 per share. The non-binding proposal states that BML holds 13% of the Company’s outstanding shares. The non-binding proposal is not subject to a financing condition but is subject to limited confirmatory due diligence and is based on the Company having at least $35 million of cash and cash equivalents as of the potential closing date of the proposed acquisition, net of any tail and closing costs, and not having issued any shares pursuant to its at-the-market offering agreement dated June 16, 2023 (the “ATM Agreement”). Effective June 27, 2023, the Company terminated the ATM Agreement in accordance with its terms.
Consistent with its fiduciary duties, the Company’s board of directors will evaluate the non-binding proposal to determine the course of action that it believes is in the best interest of the Company and all Astrotech stockholders and respond appropriately. The Astrotech stockholders do not need to take any action at this time.
About Astrotech Corporation
Astrotech (Nasdaq: ASTC) is a mass spectrometry company that launches, manages, and commercializes scalable companies based on its innovative core technology through its wholly-owned subsidiaries. 1st Detect develops, manufactures, and sells trace detectors for use in the security and detection market. AgLAB is developing chemical analyzers for use in the agriculture market. BreathTech is developing a breath analysis tool to provide early detection of lung diseases. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com.
Astrotech Corporation (ASTC) : 13,13 +13,78%
June 26, 2023
Board of Directors
Astrotech Corporation
c/o Thomas B. Pickens III, Chief Executive Officer
2105 Donley Drive, Suite 100
Austin, Texas 78758
Dear Directors,
As you are aware, BML Investment Partners, L.P. owns 13% of the shares of Astrotech and is
your largest shareholder. I was disappointed to see the company file an at-the-market (ATM)
offering on June 16, 2023. I believe that your shares are significantly undervalued, as they trade
at a large discount to net cash, and that any shares issued at this level would rapidly destroy
shareholder value. Considering these facts, I believe that shareholders would be better off if the
company was either sold or liquidated.
On behalf of BML Capital Management, LLC and BML Investment Partners, L.P., I am pleased
to submit this non-binding proposal to acquire 100% of the equity of Astrotech Corporation for
$17.25 per share in cash, which represents a 50% premium to the closing price on Friday, June
23.
This proposal is subject to limited confirmatory due diligence and is based on Astrotech having
at least $35 million of cash and cash equivalents at closing, net of any tail and closing costs, and
not having issued any shares under the ATM offering. This proposal is not subject to any
financing contingency, as we have funds readily available to close this transaction.
I believe that this proposal represents a compelling offer for Astrotech stockholders. I hope that
you share this view and look forward to discussing it with you further. I would appreciate a
response by 5pm ET on June 30, 2023, at which point this offer will expire.
Sincerely,
Braden Leonard
Total Cash (mrq) 44.15M
Total Cash Per Share (mrq) 26.21
Total Debt (mrq) 576k
Book Value Per Share (mrq) 27.75
Jun 01, 2023 11.36 11.78 10.89 11.40 11.40 35,600
May 01, 2023 10.34 11.95 10.04 11.50 11.50 115,000
Apr 01, 2023 10.65 11.00 10.14 10.40 10.40 45,400
Mar 01, 2023 12.87 13.01 10.10 10.66 10.66 96,900
Feb 01, 2023 12.10 14.07 11.53 12.95 12.95 443,400
Jan 01, 2023 9.99 12.34 9.99 12.09 12.09 125,800
Dec 01, 2022 9.90 11.82 9.28 9.99 9.99 547,217
Nov 01, 2022 12.00 13.50 9.30 10.20 10.20 301,281
Oct 01, 2022 13.20 13.80 10.20 12.30 12.30 183,265
Sep 01, 2022 13.80 14.40 12.30 13.20 13.20 204,439
Aug 01, 2022 13.80 16.20 12.30 13.80 13.80 263,144
Jul 01, 2022 12.60 14.70 12.60 13.80 13.80 63,550
Jun 01, 2022 16.50 17.10 12.60 12.90 12.90 107,050
May 01, 2022 15.90 16.80 14.40 16.50 16.50 98,090
Apr 01, 2022 21.60 22.20 15.90 16.20 16.20 121,183
Mar 01, 2022 21.60 23.10 19.80 21.60 21.60 192,625
Feb 01, 2022 19.20 22.20 18.00 21.30 21.30 249,151
Jan 01, 2022 20.40 23.10 18.00 19.50 19.50 234,297
Dec 01, 2021 24.30 24.60 19.50 20.40 20.40 371,402
Nov 01, 2021 31.20 33.00 22.80 24.00 24.00 522,731
Oct 01, 2021 31.50 34.50 29.10 30.90 30.90 726,944
Sep 01, 2021 33.30 33.90 28.80 31.50 31.50 391,866
Aug 01, 2021 34.50 36.30 28.20 33.30 33.30 1,657,386
Jul 01, 2021 41.40 42.00 30.00 32.40 32.40 963,596
Jun 01, 2021 35.40 39.90 33.60 39.90 39.90 1,113,366
May 01, 2021 36.90 37.20 30.90 35.10 35.10 998,583
Apr 01, 2021 66.60 89.40 32.10 36.90 36.90 6,113,055
Mar 01, 2021 70.50 76.20 42.90 65.70 65.70 1,323,382
Feb 01, 2021 59.40 124.20 59.40 65.70 65.70 2,390,276
Astrotech Corporation (ASTC) : 13,13 +13,78%
June 26, 2023
Board of Directors
Astrotech Corporation
c/o Thomas B. Pickens III, Chief Executive Officer
2105 Donley Drive, Suite 100
Austin, Texas 78758
Dear Directors,
As you are aware, BML Investment Partners, L.P. owns 13% of the shares of Astrotech and is
your largest shareholder. I was disappointed to see the company file an at-the-market (ATM)
offering on June 16, 2023. I believe that your shares are significantly undervalued, as they trade
at a large discount to net cash, and that any shares issued at this level would rapidly destroy
shareholder value. Considering these facts, I believe that shareholders would be better off if the
company was either sold or liquidated.
On behalf of BML Capital Management, LLC and BML Investment Partners, L.P., I am pleased
to submit this non-binding proposal to acquire 100% of the equity of Astrotech Corporation for
$17.25 per share in cash, which represents a 50% premium to the closing price on Friday, June
23.
This proposal is subject to limited confirmatory due diligence and is based on Astrotech having
at least $35 million of cash and cash equivalents at closing, net of any tail and closing costs, and
not having issued any shares under the ATM offering. This proposal is not subject to any
financing contingency, as we have funds readily available to close this transaction.
I believe that this proposal represents a compelling offer for Astrotech stockholders. I hope that
you share this view and look forward to discussing it with you further. I would appreciate a
response by 5pm ET on June 30, 2023, at which point this offer will expire.
Sincerely,
Braden Leonard
Total Cash (mrq) 44.15M
Total Cash Per Share (mrq) 26.21
Total Debt (mrq) 576k
Book Value Per Share (mrq) 27.75
Jun 01, 2023 11.36 11.78 10.89 11.40 11.40 35,600
May 01, 2023 10.34 11.95 10.04 11.50 11.50 115,000
Apr 01, 2023 10.65 11.00 10.14 10.40 10.40 45,400
Mar 01, 2023 12.87 13.01 10.10 10.66 10.66 96,900
Feb 01, 2023 12.10 14.07 11.53 12.95 12.95 443,400
Jan 01, 2023 9.99 12.34 9.99 12.09 12.09 125,800
Dec 01, 2022 9.90 11.82 9.28 9.99 9.99 547,217
Nov 01, 2022 12.00 13.50 9.30 10.20 10.20 301,281
Oct 01, 2022 13.20 13.80 10.20 12.30 12.30 183,265
Sep 01, 2022 13.80 14.40 12.30 13.20 13.20 204,439
Aug 01, 2022 13.80 16.20 12.30 13.80 13.80 263,144
Jul 01, 2022 12.60 14.70 12.60 13.80 13.80 63,550
Jun 01, 2022 16.50 17.10 12.60 12.90 12.90 107,050
May 01, 2022 15.90 16.80 14.40 16.50 16.50 98,090
Apr 01, 2022 21.60 22.20 15.90 16.20 16.20 121,183
Mar 01, 2022 21.60 23.10 19.80 21.60 21.60 192,625
Feb 01, 2022 19.20 22.20 18.00 21.30 21.30 249,151
Jan 01, 2022 20.40 23.10 18.00 19.50 19.50 234,297
Dec 01, 2021 24.30 24.60 19.50 20.40 20.40 371,402
Nov 01, 2021 31.20 33.00 22.80 24.00 24.00 522,731
Oct 01, 2021 31.50 34.50 29.10 30.90 30.90 726,944
Sep 01, 2021 33.30 33.90 28.80 31.50 31.50 391,866
Aug 01, 2021 34.50 36.30 28.20 33.30 33.30 1,657,386
Jul 01, 2021 41.40 42.00 30.00 32.40 32.40 963,596
Jun 01, 2021 35.40 39.90 33.60 39.90 39.90 1,113,366
May 01, 2021 36.90 37.20 30.90 35.10 35.10 998,583
Apr 01, 2021 66.60 89.40 32.10 36.90 36.90 6,113,055
Mar 01, 2021 70.50 76.20 42.90 65.70 65.70 1,323,382
Feb 01, 2021 59.40 124.20 59.40 65.70 65.70 2,390,276
ReShape Lifesciences Inc. (RSLS) : 1.7500+0.0600 (+3.55%)
After-Hours Volume 2,901,613
After-Hours High $2.95 + 1.20 (+68.61%)
ReShape Lifesciences® Submits FDA PMA Supplement Application for the Next-Generation Lap-Band® 2.0
ReShape Lifesciences Inc
Mon, June 26, 2023 at 10:05 PM GMT+2
Enhanced Band Reservoir Technology Designed to Improve the Patient Experience
IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the submission of a Premarket Approval (PMA) supplement application to the U.S. Food and Drug Administration (FDA) for the company’s next generation, enhanced Lap-Band® 2.0, utilizing a band reservoir technology.
“The PMA supplement submission is a significant milestone and is consistent with our second growth pillar to develop and, ultimately, commercialize new products and therapies,” stated Paul F. Hickey, President and Chief Executive Officer of ReShape Lifesciences. “This next generation, enhanced Lap-Band® 2.0 was developed with physician feedback to improve the patient experience. Similar to our current Lap-Band, the Lap-Band 2.0 is adjustable postoperatively to increase or decrease the opening of the band in order to optimize an individual’s comfort, thereby improving therapy effectiveness. However, unique to the Lap-Band 2.0 is an enhanced band reservoir technology that serves as a relief valve, designed to alleviate discomfort from swallowing large pieces of food, that may require in-office band adjustments. We expect feedback from the FDA by year end. If approved, we believe that based on discussions with physicians, that there will be broad adoption by existing Lap-Band® surgeons and surgeons that newly adopt the Lap-Band® 2.0.”
About ReShape Lifesciences®
ReShape Lifesciences® is America’s premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band® System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. ReShapeCare™ is a virtual weight-management program that supports lifestyle changes for all weight loss patients led by board-certified health coaches to help them keep the weight off over time. ReShape Marketplace™ is an online collection of quality wellness products curated for all consumers to help them achieve their health goals. The investigational Diabetes Bloc-Stim Neuromodulation™ (DBSN™) system utilizes a proprietary vagus nerve block and stimulation technology platform for the treatment of Type 2 diabetes and metabolic disorders. The Obalon® balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. For more information, please visit www.reshapelifesciences.com.
Jun 19, 2023 2.1100 2.4480 1.6500 1.6800 1.6800 1,003,500
Jun 12, 2023 2.3500 2.4400 2.1000 2.1100 2.1100 339,300
Jun 05, 2023 2.5850 2.5850 2.3320 2.3800 2.3800 199,200
May 29, 2023 2.5140 2.5600 2.3700 2.5200 2.5200 135,000
May 22, 2023 2.5200 2.7600 2.4700 2.5600 2.5600 272,900
May 15, 2023 2.3800 2.6690 2.2600 2.5200 2.5200 422,500
May 08, 2023 2.4500 2.7980 2.3200 2.3800 2.3800 530,500
May 01, 2023 2.3500 2.7000 2.3000 2.3800 2.3800 604,500
Apr 24, 2023 2.7500 2.7900 2.2100 2.2700 2.2700 457,500
Apr 17, 2023 2.6800 4.1000 2.6720 2.7500 2.7500 5,047,800
Apr 10, 2023 2.6800 3.8900 2.5700 2.7000 2.7000 5,020,400
Apr 03, 2023 2.6000 2.9800 2.5200 2.7500 2.7500 465,400
Mar 27, 2023 3.0400 3.1700 2.5000 2.5700 2.5700 550,200
Mar 20, 2023 3.1600 3.5600 2.6700 3.0800 3.0800 2,315,900
Mar 13, 2023 3.3200 3.3290 2.4900 2.6600 2.6600 543,800
Mar 06, 2023 4.4700 4.4700 3.2000 3.3500 3.3500 730,900
Feb 27, 2023 4.0000 4.5800 4.0000 4.4700 4.4700 669,800
Feb 20, 2023 4.9000 5.3900 3.9400 4.0300 4.0300 1,329,300
Feb 13, 2023 4.9000 5.5000 3.8300 5.0000 5.0000 6,166,900
Feb 06, 2023 6.5000 8.2000 5.0000 5.0200 5.0200 13,509,200
Jan 30, 2023 8.1400 22.4000 6.0600 17.0400 17.0400 12,624,600
Jan 23, 2023 7.5400 8.4100 7.3700 7.8700 7.8700 165,500
Jan 16, 2023 8.3800 8.5400 7.1100 7.6800 7.6800 93,100
Jan 09, 2023 7.5100 9.1100 7.1800 8.7200 8.7200 358,200
Jan 02, 2023 9.6600 20.6300 7.0800 7.2600 7.2600 13,614,600
ReShape Lifesciences Inc. (RSLS) : 1.7500+0.0600 (+3.55%)
After-Hours Volume 2,901,613
After-Hours High $2.95 + 1.20 (+68.61%)
ReShape Lifesciences® Submits FDA PMA Supplement Application for the Next-Generation Lap-Band® 2.0
ReShape Lifesciences Inc
Mon, June 26, 2023 at 10:05 PM GMT+2
Enhanced Band Reservoir Technology Designed to Improve the Patient Experience
IRVINE, Calif., June 26, 2023 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced the submission of a Premarket Approval (PMA) supplement application to the U.S. Food and Drug Administration (FDA) for the company’s next generation, enhanced Lap-Band® 2.0, utilizing a band reservoir technology.
“The PMA supplement submission is a significant milestone and is consistent with our second growth pillar to develop and, ultimately, commercialize new products and therapies,” stated Paul F. Hickey, President and Chief Executive Officer of ReShape Lifesciences. “This next generation, enhanced Lap-Band® 2.0 was developed with physician feedback to improve the patient experience. Similar to our current Lap-Band, the Lap-Band 2.0 is adjustable postoperatively to increase or decrease the opening of the band in order to optimize an individual’s comfort, thereby improving therapy effectiveness. However, unique to the Lap-Band 2.0 is an enhanced band reservoir technology that serves as a relief valve, designed to alleviate discomfort from swallowing large pieces of food, that may require in-office band adjustments. We expect feedback from the FDA by year end. If approved, we believe that based on discussions with physicians, that there will be broad adoption by existing Lap-Band® surgeons and surgeons that newly adopt the Lap-Band® 2.0.”
About ReShape Lifesciences®
ReShape Lifesciences® is America’s premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band® System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. ReShapeCare™ is a virtual weight-management program that supports lifestyle changes for all weight loss patients led by board-certified health coaches to help them keep the weight off over time. ReShape Marketplace™ is an online collection of quality wellness products curated for all consumers to help them achieve their health goals. The investigational Diabetes Bloc-Stim Neuromodulation™ (DBSN™) system utilizes a proprietary vagus nerve block and stimulation technology platform for the treatment of Type 2 diabetes and metabolic disorders. The Obalon® balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. For more information, please visit www.reshapelifesciences.com.
Jun 19, 2023 2.1100 2.4480 1.6500 1.6800 1.6800 1,003,500
Jun 12, 2023 2.3500 2.4400 2.1000 2.1100 2.1100 339,300
Jun 05, 2023 2.5850 2.5850 2.3320 2.3800 2.3800 199,200
May 29, 2023 2.5140 2.5600 2.3700 2.5200 2.5200 135,000
May 22, 2023 2.5200 2.7600 2.4700 2.5600 2.5600 272,900
May 15, 2023 2.3800 2.6690 2.2600 2.5200 2.5200 422,500
May 08, 2023 2.4500 2.7980 2.3200 2.3800 2.3800 530,500
May 01, 2023 2.3500 2.7000 2.3000 2.3800 2.3800 604,500
Apr 24, 2023 2.7500 2.7900 2.2100 2.2700 2.2700 457,500
Apr 17, 2023 2.6800 4.1000 2.6720 2.7500 2.7500 5,047,800
Apr 10, 2023 2.6800 3.8900 2.5700 2.7000 2.7000 5,020,400
Apr 03, 2023 2.6000 2.9800 2.5200 2.7500 2.7500 465,400
Mar 27, 2023 3.0400 3.1700 2.5000 2.5700 2.5700 550,200
Mar 20, 2023 3.1600 3.5600 2.6700 3.0800 3.0800 2,315,900
Mar 13, 2023 3.3200 3.3290 2.4900 2.6600 2.6600 543,800
Mar 06, 2023 4.4700 4.4700 3.2000 3.3500 3.3500 730,900
Feb 27, 2023 4.0000 4.5800 4.0000 4.4700 4.4700 669,800
Feb 20, 2023 4.9000 5.3900 3.9400 4.0300 4.0300 1,329,300
Feb 13, 2023 4.9000 5.5000 3.8300 5.0000 5.0000 6,166,900
Feb 06, 2023 6.5000 8.2000 5.0000 5.0200 5.0200 13,509,200
Jan 30, 2023 8.1400 22.4000 6.0600 17.0400 17.0400 12,624,600
Jan 23, 2023 7.5400 8.4100 7.3700 7.8700 7.8700 165,500
Jan 16, 2023 8.3800 8.5400 7.1100 7.6800 7.6800 93,100
Jan 09, 2023 7.5100 9.1100 7.1800 8.7200 8.7200 358,200
Jan 02, 2023 9.6600 20.6300 7.0800 7.2600 7.2600 13,614,600
Astrotech Corporation (ASTC) : 11.54+0.04 (+0.35%)
After hours: 15.29 3.75 (+32.51%)
I hope we see at least $16 tomorrow
June 26, 2023
Board of Directors
Astrotech Corporation
c/o Thomas B. Pickens III, Chief Executive Officer
2105 Donley Drive, Suite 100
Austin, Texas 78758
Dear Directors,
As you are aware, BML Investment Partners, L.P. owns 13% of the shares of Astrotech and is
your largest shareholder. I was disappointed to see the company file an at-the-market (ATM)
offering on June 16, 2023. I believe that your shares are significantly undervalued, as they trade
at a large discount to net cash, and that any shares issued at this level would rapidly destroy
shareholder value. Considering these facts, I believe that shareholders would be better off if the
company was either sold or liquidated.
On behalf of BML Capital Management, LLC and BML Investment Partners, L.P., I am pleased
to submit this non-binding proposal to acquire 100% of the equity of Astrotech Corporation for
$17.25 per share in cash, which represents a 50% premium to the closing price on Friday, June
23.
This proposal is subject to limited confirmatory due diligence and is based on Astrotech having
at least $35 million of cash and cash equivalents at closing, net of any tail and closing costs, and
not having issued any shares under the ATM offering. This proposal is not subject to any
financing contingency, as we have funds readily available to close this transaction.
I believe that this proposal represents a compelling offer for Astrotech stockholders. I hope that
you share this view and look forward to discussing it with you further. I would appreciate a
response by 5pm ET on June 30, 2023, at which point this offer will expire.
Sincerely,
Braden Leonard
Total Cash (mrq) 44.15M
Total Cash Per Share (mrq) 26.21
Total Debt (mrq) 576k
Book Value Per Share (mrq) 27.75
Jun 01, 2023 11.36 11.78 10.89 11.40 11.40 35,600
May 01, 2023 10.34 11.95 10.04 11.50 11.50 115,000
Apr 01, 2023 10.65 11.00 10.14 10.40 10.40 45,400
Mar 01, 2023 12.87 13.01 10.10 10.66 10.66 96,900
Feb 01, 2023 12.10 14.07 11.53 12.95 12.95 443,400
Jan 01, 2023 9.99 12.34 9.99 12.09 12.09 125,800
Dec 01, 2022 9.90 11.82 9.28 9.99 9.99 547,217
Nov 01, 2022 12.00 13.50 9.30 10.20 10.20 301,281
Oct 01, 2022 13.20 13.80 10.20 12.30 12.30 183,265
Sep 01, 2022 13.80 14.40 12.30 13.20 13.20 204,439
Aug 01, 2022 13.80 16.20 12.30 13.80 13.80 263,144
Jul 01, 2022 12.60 14.70 12.60 13.80 13.80 63,550
Jun 01, 2022 16.50 17.10 12.60 12.90 12.90 107,050
May 01, 2022 15.90 16.80 14.40 16.50 16.50 98,090
Apr 01, 2022 21.60 22.20 15.90 16.20 16.20 121,183
Mar 01, 2022 21.60 23.10 19.80 21.60 21.60 192,625
Feb 01, 2022 19.20 22.20 18.00 21.30 21.30 249,151
Jan 01, 2022 20.40 23.10 18.00 19.50 19.50 234,297
Dec 01, 2021 24.30 24.60 19.50 20.40 20.40 371,402
Nov 01, 2021 31.20 33.00 22.80 24.00 24.00 522,731
Oct 01, 2021 31.50 34.50 29.10 30.90 30.90 726,944
Sep 01, 2021 33.30 33.90 28.80 31.50 31.50 391,866
Aug 01, 2021 34.50 36.30 28.20 33.30 33.30 1,657,386
Jul 01, 2021 41.40 42.00 30.00 32.40 32.40 963,596
Jun 01, 2021 35.40 39.90 33.60 39.90 39.90 1,113,366
May 01, 2021 36.90 37.20 30.90 35.10 35.10 998,583
Apr 01, 2021 66.60 89.40 32.10 36.90 36.90 6,113,055
Mar 01, 2021 70.50 76.20 42.90 65.70 65.70 1,323,382
Feb 01, 2021 59.40 124.20 59.40 65.70 65.70 2,390,276
Astrotech Corporation (ASTC) : 11.54+0.04 (+0.35%)
After hours: 15.29 3.75 (+32.51%)
I hope we see at least $16 tomorrow
June 26, 2023
Board of Directors
Astrotech Corporation
c/o Thomas B. Pickens III, Chief Executive Officer
2105 Donley Drive, Suite 100
Austin, Texas 78758
Dear Directors,
As you are aware, BML Investment Partners, L.P. owns 13% of the shares of Astrotech and is
your largest shareholder. I was disappointed to see the company file an at-the-market (ATM)
offering on June 16, 2023. I believe that your shares are significantly undervalued, as they trade
at a large discount to net cash, and that any shares issued at this level would rapidly destroy
shareholder value. Considering these facts, I believe that shareholders would be better off if the
company was either sold or liquidated.
On behalf of BML Capital Management, LLC and BML Investment Partners, L.P., I am pleased
to submit this non-binding proposal to acquire 100% of the equity of Astrotech Corporation for
$17.25 per share in cash, which represents a 50% premium to the closing price on Friday, June
23.
This proposal is subject to limited confirmatory due diligence and is based on Astrotech having
at least $35 million of cash and cash equivalents at closing, net of any tail and closing costs, and
not having issued any shares under the ATM offering. This proposal is not subject to any
financing contingency, as we have funds readily available to close this transaction.
I believe that this proposal represents a compelling offer for Astrotech stockholders. I hope that
you share this view and look forward to discussing it with you further. I would appreciate a
response by 5pm ET on June 30, 2023, at which point this offer will expire.
Sincerely,
Braden Leonard
Total Cash (mrq) 44.15M
Total Cash Per Share (mrq) 26.21
Total Debt (mrq) 576k
Book Value Per Share (mrq) 27.75
Jun 01, 2023 11.36 11.78 10.89 11.40 11.40 35,600
May 01, 2023 10.34 11.95 10.04 11.50 11.50 115,000
Apr 01, 2023 10.65 11.00 10.14 10.40 10.40 45,400
Mar 01, 2023 12.87 13.01 10.10 10.66 10.66 96,900
Feb 01, 2023 12.10 14.07 11.53 12.95 12.95 443,400
Jan 01, 2023 9.99 12.34 9.99 12.09 12.09 125,800
Dec 01, 2022 9.90 11.82 9.28 9.99 9.99 547,217
Nov 01, 2022 12.00 13.50 9.30 10.20 10.20 301,281
Oct 01, 2022 13.20 13.80 10.20 12.30 12.30 183,265
Sep 01, 2022 13.80 14.40 12.30 13.20 13.20 204,439
Aug 01, 2022 13.80 16.20 12.30 13.80 13.80 263,144
Jul 01, 2022 12.60 14.70 12.60 13.80 13.80 63,550
Jun 01, 2022 16.50 17.10 12.60 12.90 12.90 107,050
May 01, 2022 15.90 16.80 14.40 16.50 16.50 98,090
Apr 01, 2022 21.60 22.20 15.90 16.20 16.20 121,183
Mar 01, 2022 21.60 23.10 19.80 21.60 21.60 192,625
Feb 01, 2022 19.20 22.20 18.00 21.30 21.30 249,151
Jan 01, 2022 20.40 23.10 18.00 19.50 19.50 234,297
Dec 01, 2021 24.30 24.60 19.50 20.40 20.40 371,402
Nov 01, 2021 31.20 33.00 22.80 24.00 24.00 522,731
Oct 01, 2021 31.50 34.50 29.10 30.90 30.90 726,944
Sep 01, 2021 33.30 33.90 28.80 31.50 31.50 391,866
Aug 01, 2021 34.50 36.30 28.20 33.30 33.30 1,657,386
Jul 01, 2021 41.40 42.00 30.00 32.40 32.40 963,596
Jun 01, 2021 35.40 39.90 33.60 39.90 39.90 1,113,366
May 01, 2021 36.90 37.20 30.90 35.10 35.10 998,583
Apr 01, 2021 66.60 89.40 32.10 36.90 36.90 6,113,055
Mar 01, 2021 70.50 76.20 42.90 65.70 65.70 1,323,382
Feb 01, 2021 59.40 124.20 59.40 65.70 65.70 2,390,276
Taoping Inc. (TAOP) : 0.799 +0.0490 (+6.54%)
52w: 0.56 - 1.75
SHENZHEN, June 26, 2023 /PRNewswire/ -- Taoping Inc. (NASDAQ: TAOP, the "Company" or "Taoping"), today announced the Company is expanding into the Jiangxi Province and has entered into a new strategic cooperation agreement with Anyuan County to provide customized AI-aided Smart City solutions, which will leverage the Company's powerful new Cloud Nest AI system and intelligent Cloud platform to significantly help local digital transformation and development and ecological civilization construction.
(PRNewsfoto/Taoping Inc.)
(PRNewsfoto/Taoping Inc.)
Anyuan County is located in Jiangxi Province, China, with 18 towns under its jurisdiction and a population of about 400,000. The city is renowned for its cultural heritage, valuable tourism resources and ecological protection.
The strategic agreement is part of Anyuan County's Smart City transformation, with a dedicated economic and digital transformation. The parties will work together to implement a variety of Smart City programs and solutions, while also implementing tailored environmental enrichment solutions to protect the source water of the Dongjiang River, which supplies water to Hong Kong, and plays an important role to support the development of Guangdong-Hong Kong-Macao Greater Bay Area.
Under the agreement, the two parties will carry out comprehensive cooperation in the fields of industrial investment, human intelligence, low-carbon environmental protection, Smart City renewal and rural ecological revitalization. The integrated solutions are 5G, AI-aided, Cloud-based and underpinned by Taoping's proprietary operating software. Taoping will provide its innovative Smart Rest Stations, lower cost, portable off-grid wastewater treatment solutions, and other related products and services, while Anyuan County provides market resources, policy support and fully assists the operation and development of the Company's projects in Anyuan County and surrounding counties and cities.
Mr. Lin Jianghuai, Chairman and CEO of Taoping, said: "This is another big win for us with high strategic value. We continue to drive expansion into new geographies as we sell our customized Smart City solutions. We are benefitting from increased interest as municipalities seek to modernize for the benefit of residents and tourists, while driving operating and maintenance costs lower through increased efficiencies that come with our Cloud-based platform. We expect this deal to serve as an example for other municipalities. Smart City investments are also smart for business and an important factor when people decide where they want to work, live and play."
Under the initial phase of the cooperation, Taoping will help implement its new lower cost, portable off-grid wastewater treatment product across five townships. Taoping will gradually roll out the application in the entire county of Anyuan County, and contribute scientific and technological strength to the ecological environment protection at the source of the Dongjiang River. Taoping's AI-aided products and solutions will help to further improve the independent decision-making and processing capabilities of Anyuan County's evolving Smart City ecosystem and infrastructure, while allowing for greater scalability in the implementation and operation of ongoing development, more efficient operation and maintenance, and overall environmental protection capabilities.
SHENZHEN, China, June 20, 2023 /PRNewswire/ -- Taoping Inc. (NASDAQ: TAOP, the "Company" or "Taoping"), today announced the launch of the Company's AI-aided innovative new, rapid, off-grid wastewater treatment solutions designed to bring "Clean Water for a Cleaner World". The lower cost, portable wastewater treatment solutions represent a watershed moment in the global effort for a cleaner environment, and will be integrated with Taoping's intelligent operation and maintenance system aided by the Company's powerful new Cloud Nest AI system and intelligent Cloud platform to significantly increase operations and cost efficiencies of maintenance management.
(PRNewsfoto/Taoping Inc.)
(PRNewsfoto/Taoping Inc.)
Underserved rural markets will be a top priority for Taoping's new off-grid wastewater treatment solutions. The market size for wastewater treatment for the rural areas of China is estimated to be approximately RMB 300 billion in 2023, with a CAGR of 10% over the next 5 years. (source: Zhongtou Consultant)
The off-grid wastewater treatment solutions market refers to the market for wastewater treatment systems that operate without being connected to the grid. These systems are typically used in remote or rural areas where traditional wastewater treatment infrastructure is not available. The off-grid wastewater treatment solutions market is expected to grow in the coming years, driven by increasing demand from developing countries and remote areas.
Mr. Lin Jianghuai, Chairman and CEO of Taoping, said: "There is growing demand for off-grid wastewater treatment solutions due to several factors, including increasing population growth, urbanization, and environmental concerns. Additionally, the cost of traditional wastewater treatment infrastructure can be prohibitively expensive in remote areas, making off-grid solutions an attractive alternative. Taoping's purpose built wastewater treatment solutions provide a portable, on-site solution with lower upfront and maintenance costs, that leverages the advantages of traditional solutions, while offering highly compelling performance, Cloud-based monitoring, maintenance and cost advantages. More importantly, the Company's intelligent operation and maintenance system aided by Taoping's powerful new Cloud Nest AI system and intelligent Cloud platform can increase operations and cost efficiencies of maintenance management, truly realizing the automatic operation of sewage treatment facilities in low- and medium-density urban and rural residential areas, which we expect will make this a preferred choice that is more attractive to the market."
Mr. Lin continued: "We are very excited about the long-term opportunities for Taoping's wastewater treatment solutions. We are committed to helping customers and communities create a more sustainable future with Clean Water for a Cleaner World. We are taking a cyclical approach to managing wastewater that emphasizes the effectiveness of our innovative new wastewater treatment solutions, as we reinforce our commitment to both environmental sustainability and efficient wastewater management. We will continue to promote the deep integration of AI technology and sewage treatment products to build a new wastewater environment management integration platform with low cost, hassle free construction, intelligent operation and maintenance, convenient operation, and reduced cost of clear ownership to form valuable brand assets and drive the Company's revenue growth."
Off-grid wastewater treatment refers to the method of onsite wastewater treatment in the smallest unit of wastewater source as far as possible in the middle and low population density residential areas. For example, in individual farmers, B&Bs, villas, public toilets, schools, hospitals, hotels, residential communities, parks, urban villages, temporary construction sites, islands and other sources of domestic wastewater treatment after discharge or reuse standards. Taopping's off-grid wastewater treatment solutions are able to treat wastewater from a single source or multiple sources.
SHENZHEN, China, June 15, 2023 /PRNewswire/ -- Taoping Inc. (NASDAQ: TAOP, the "Company" or "Taoping"), today announced the Company plans to launch Cloud Nest AI, a powerful generative AI system across the Cloud to accelerate growth. Cloud Nest AI will leverage the Company's existing cloud-based technology and applications and integrate AI with intelligent Cloud platform technology and product capabilities. End users are empowered with smart scene terminals, that deeply integrate numerous industry-specific application scenarios across all major industries and subsegments.
(PRNewsfoto/Taoping Inc.)
(PRNewsfoto/Taoping Inc.)
Taoping's industry specific applications for different scenarios based on the Cloud Nest AI system are expected to provide multi-dimensional empowerment for various industries from multiple perspectives, such as content generation, human-computer interaction, visual perception, and cognitive decision-making. In the field of advertising media, Taoping's cloud platform allows advertisers to provide creative content, such as graphics, videos, and texts for specific promotional strategies, while artificial intelligence can then effectively develop mixed-media promotions.
Taoping will also integrate the new generative AI system into its other smart solutions to better help customers harness the latest technology development to achieve a higher return on investment, lower cost of ownership, an improved overall customer experience. This includes the Company's intelligent cleaning robots, which are pushing industry-leading performance in terms of unmanned driving, intelligent decision-making, and human-machine collaboration to solve complex urban outdoor and indoor scenarios. Another example is in the field of ecological environmental protection, where the Company's off-grid sewage treatment equipment adopts microbial control technology and intelligent monitoring system to accurately implement sewage treatment from the source of sewage generation, which is highly efficient, energy-saving and environmentally friendly.
Mr. Lin Jianghuai, Chairman and CEO of Taoping, said: "The Cloud Nest AI generative AI system will be another important milestone based on the strategic upgrade of Taoping's Cloud-based technology and applications. We have been investing in and actively deploying a series of exciting new products to help our customers better embrace superior new technologies and systems, which in return will accelerate our revenue growth. We look forward to continuing to open new commercial and industrial opportunities for our Cloud Nest generative AI system, and will keep the market updated on our progress."
About Taoping Inc.
Taoping Inc. (Nasdaq: TAOP) has a long history of successfully leveraging technology in the development of innovative solutions to help customers in both the private and public sectors to more effectively communicate and market to their desired targets. The Company has built a far-reaching city partner ecosystem and comprehensive portfolio of high-value, high-traffic areas for its products, which are aligned together with Taoping's smart cloud platform, cloud services and solutions, new media and artificial intelligence. For more information about Taoping, please visit www.taop.com. You can also follow us via LinkedIn, Twitter or YouTube.
Taoping Inc. (TAOP) : 0.799 +0.0490 (+6.54%)
52w: 0.56 - 1.75
SHENZHEN, June 26, 2023 /PRNewswire/ -- Taoping Inc. (NASDAQ: TAOP, the "Company" or "Taoping"), today announced the Company is expanding into the Jiangxi Province and has entered into a new strategic cooperation agreement with Anyuan County to provide customized AI-aided Smart City solutions, which will leverage the Company's powerful new Cloud Nest AI system and intelligent Cloud platform to significantly help local digital transformation and development and ecological civilization construction.
(PRNewsfoto/Taoping Inc.)
(PRNewsfoto/Taoping Inc.)
Anyuan County is located in Jiangxi Province, China, with 18 towns under its jurisdiction and a population of about 400,000. The city is renowned for its cultural heritage, valuable tourism resources and ecological protection.
The strategic agreement is part of Anyuan County's Smart City transformation, with a dedicated economic and digital transformation. The parties will work together to implement a variety of Smart City programs and solutions, while also implementing tailored environmental enrichment solutions to protect the source water of the Dongjiang River, which supplies water to Hong Kong, and plays an important role to support the development of Guangdong-Hong Kong-Macao Greater Bay Area.
Under the agreement, the two parties will carry out comprehensive cooperation in the fields of industrial investment, human intelligence, low-carbon environmental protection, Smart City renewal and rural ecological revitalization. The integrated solutions are 5G, AI-aided, Cloud-based and underpinned by Taoping's proprietary operating software. Taoping will provide its innovative Smart Rest Stations, lower cost, portable off-grid wastewater treatment solutions, and other related products and services, while Anyuan County provides market resources, policy support and fully assists the operation and development of the Company's projects in Anyuan County and surrounding counties and cities.
Mr. Lin Jianghuai, Chairman and CEO of Taoping, said: "This is another big win for us with high strategic value. We continue to drive expansion into new geographies as we sell our customized Smart City solutions. We are benefitting from increased interest as municipalities seek to modernize for the benefit of residents and tourists, while driving operating and maintenance costs lower through increased efficiencies that come with our Cloud-based platform. We expect this deal to serve as an example for other municipalities. Smart City investments are also smart for business and an important factor when people decide where they want to work, live and play."
Under the initial phase of the cooperation, Taoping will help implement its new lower cost, portable off-grid wastewater treatment product across five townships. Taoping will gradually roll out the application in the entire county of Anyuan County, and contribute scientific and technological strength to the ecological environment protection at the source of the Dongjiang River. Taoping's AI-aided products and solutions will help to further improve the independent decision-making and processing capabilities of Anyuan County's evolving Smart City ecosystem and infrastructure, while allowing for greater scalability in the implementation and operation of ongoing development, more efficient operation and maintenance, and overall environmental protection capabilities.
SHENZHEN, China, June 20, 2023 /PRNewswire/ -- Taoping Inc. (NASDAQ: TAOP, the "Company" or "Taoping"), today announced the launch of the Company's AI-aided innovative new, rapid, off-grid wastewater treatment solutions designed to bring "Clean Water for a Cleaner World". The lower cost, portable wastewater treatment solutions represent a watershed moment in the global effort for a cleaner environment, and will be integrated with Taoping's intelligent operation and maintenance system aided by the Company's powerful new Cloud Nest AI system and intelligent Cloud platform to significantly increase operations and cost efficiencies of maintenance management.
(PRNewsfoto/Taoping Inc.)
(PRNewsfoto/Taoping Inc.)
Underserved rural markets will be a top priority for Taoping's new off-grid wastewater treatment solutions. The market size for wastewater treatment for the rural areas of China is estimated to be approximately RMB 300 billion in 2023, with a CAGR of 10% over the next 5 years. (source: Zhongtou Consultant)
The off-grid wastewater treatment solutions market refers to the market for wastewater treatment systems that operate without being connected to the grid. These systems are typically used in remote or rural areas where traditional wastewater treatment infrastructure is not available. The off-grid wastewater treatment solutions market is expected to grow in the coming years, driven by increasing demand from developing countries and remote areas.
Mr. Lin Jianghuai, Chairman and CEO of Taoping, said: "There is growing demand for off-grid wastewater treatment solutions due to several factors, including increasing population growth, urbanization, and environmental concerns. Additionally, the cost of traditional wastewater treatment infrastructure can be prohibitively expensive in remote areas, making off-grid solutions an attractive alternative. Taoping's purpose built wastewater treatment solutions provide a portable, on-site solution with lower upfront and maintenance costs, that leverages the advantages of traditional solutions, while offering highly compelling performance, Cloud-based monitoring, maintenance and cost advantages. More importantly, the Company's intelligent operation and maintenance system aided by Taoping's powerful new Cloud Nest AI system and intelligent Cloud platform can increase operations and cost efficiencies of maintenance management, truly realizing the automatic operation of sewage treatment facilities in low- and medium-density urban and rural residential areas, which we expect will make this a preferred choice that is more attractive to the market."
Mr. Lin continued: "We are very excited about the long-term opportunities for Taoping's wastewater treatment solutions. We are committed to helping customers and communities create a more sustainable future with Clean Water for a Cleaner World. We are taking a cyclical approach to managing wastewater that emphasizes the effectiveness of our innovative new wastewater treatment solutions, as we reinforce our commitment to both environmental sustainability and efficient wastewater management. We will continue to promote the deep integration of AI technology and sewage treatment products to build a new wastewater environment management integration platform with low cost, hassle free construction, intelligent operation and maintenance, convenient operation, and reduced cost of clear ownership to form valuable brand assets and drive the Company's revenue growth."
Off-grid wastewater treatment refers to the method of onsite wastewater treatment in the smallest unit of wastewater source as far as possible in the middle and low population density residential areas. For example, in individual farmers, B&Bs, villas, public toilets, schools, hospitals, hotels, residential communities, parks, urban villages, temporary construction sites, islands and other sources of domestic wastewater treatment after discharge or reuse standards. Taopping's off-grid wastewater treatment solutions are able to treat wastewater from a single source or multiple sources.
SHENZHEN, China, June 15, 2023 /PRNewswire/ -- Taoping Inc. (NASDAQ: TAOP, the "Company" or "Taoping"), today announced the Company plans to launch Cloud Nest AI, a powerful generative AI system across the Cloud to accelerate growth. Cloud Nest AI will leverage the Company's existing cloud-based technology and applications and integrate AI with intelligent Cloud platform technology and product capabilities. End users are empowered with smart scene terminals, that deeply integrate numerous industry-specific application scenarios across all major industries and subsegments.
(PRNewsfoto/Taoping Inc.)
(PRNewsfoto/Taoping Inc.)
Taoping's industry specific applications for different scenarios based on the Cloud Nest AI system are expected to provide multi-dimensional empowerment for various industries from multiple perspectives, such as content generation, human-computer interaction, visual perception, and cognitive decision-making. In the field of advertising media, Taoping's cloud platform allows advertisers to provide creative content, such as graphics, videos, and texts for specific promotional strategies, while artificial intelligence can then effectively develop mixed-media promotions.
Taoping will also integrate the new generative AI system into its other smart solutions to better help customers harness the latest technology development to achieve a higher return on investment, lower cost of ownership, an improved overall customer experience. This includes the Company's intelligent cleaning robots, which are pushing industry-leading performance in terms of unmanned driving, intelligent decision-making, and human-machine collaboration to solve complex urban outdoor and indoor scenarios. Another example is in the field of ecological environmental protection, where the Company's off-grid sewage treatment equipment adopts microbial control technology and intelligent monitoring system to accurately implement sewage treatment from the source of sewage generation, which is highly efficient, energy-saving and environmentally friendly.
Mr. Lin Jianghuai, Chairman and CEO of Taoping, said: "The Cloud Nest AI generative AI system will be another important milestone based on the strategic upgrade of Taoping's Cloud-based technology and applications. We have been investing in and actively deploying a series of exciting new products to help our customers better embrace superior new technologies and systems, which in return will accelerate our revenue growth. We look forward to continuing to open new commercial and industrial opportunities for our Cloud Nest generative AI system, and will keep the market updated on our progress."
About Taoping Inc.
Taoping Inc. (Nasdaq: TAOP) has a long history of successfully leveraging technology in the development of innovative solutions to help customers in both the private and public sectors to more effectively communicate and market to their desired targets. The Company has built a far-reaching city partner ecosystem and comprehensive portfolio of high-value, high-traffic areas for its products, which are aligned together with Taoping's smart cloud platform, cloud services and solutions, new media and artificial intelligence. For more information about Taoping, please visit www.taop.com. You can also follow us via LinkedIn, Twitter or YouTube.
OpGen, Inc. (OPGN) :0.64
52 Week Range 0.5400 - 13.6000
OpGen Subsidiary Ares Genetics Successfully Maintains Key Patent under Opposition in Europe
Mon, June 26, 2023 at 1:30 PM GMT+2
Patent EP 3 332 028 B1 granted by the European Patent Office covers the identification and use of genomic variants for the diagnosis of antibiotic resistant bacteria.
The opposition division of European Patent Office ruled to maintain the patent as granted with minor modifications.
ROCKVILLE, Md., June 26, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, and OpGen subsidiary, Ares Genetics, which strives to become a leader in bacterial genomics and AI-powered prediction of antimicrobial resistance (AMR), announced today that one of its key patents under opposition has been successfully maintained.
The patent with the title GENETIC RESISTANCE PREDICTION AGAINST ANTIMICROBIAL DRUGS IN MICROORGANISM USING STRUCTURAL CHANGES IN THE GENOME was granted in Europe on January 6, 2021 and in China on January 10, 2023.
In September 2021, an opposition was filed by a Swedish opponent against the patent grant by the European Patent Office. In a hearing on Thursday, June 22, 2023, the opposition division of the European Patent Office ruled in favor of maintaining the patent as granted with a minor amendment to one of the claims.
The patent as maintained broadly covers the prediction of AMR in pathogens based on any genetic determinants involving two or more nucleotides.
The patent is an important component of the comprehensive intellectual property portfolio protecting Ares Genetics' unique database ARESdb and machine learning based approaches for predicting phenotypic antibiotic susceptibility and resistance directly from genomic data, an approach also referred to as “genomic AST.” Under the patent, both the computational identification of genetic determinants of AMR and genomic AST can be carried out, in order to diagnose AMR infections in patient samples.
“The patent covers the use of alignment-free methods, which are not only more computing resource efficient, but are also generally required to discover and resolve more complex structural variants, which is particularly important in this context,” says Dr. Arne Materna, CEO and Managing Director of Ares Genetics. “We therefore welcome the favorable ruling by the European Patent Office, an outcome that we believe underscores the validity, novelty and potential value of similar pending patent applications in our portfolio.”
OpGen believes that bacterial whole genome sequencing (WGS) is becoming the method of choice for detecting and controlling healthcare associated outbreaks. Genomic AST as covered in the patent has the potential to expand the utility of WGS beyond outbreak-surveillance into the realm of diagnostic applications to inform therapy.
About OpGen, Inc.
OpGen, Inc. (Rockville, Md, U.S.A.) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. Along with our subsidiaries, Curetis GmbH and Ares Genetics GmbH, we are developing and commercializing molecular microbiology solutions helping to guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs. OpGen’s current product portfolio includes Unyvero, Acuitas AMR Gene Panel, and the ARES Technology Platform including ARESdb, NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction including ARESiss, ARESid, ARESasp and AREScloud, as well as the Curetis CE-IVD-marked PCR-based SARS-CoV-2 test kit.
For more information, please visit www.opgen.com.
time for a strong recovery:
Jun 21, 2023 0.5900 0.6300 0.5400 0.6300 0.6300 364,754
Jun 19, 2023 0.6000 0.6300 0.5400 0.6300 0.6300 527,300
Jun 12, 2023 0.6400 0.7200 0.5800 0.6000 0.6000 1,968,700
Jun 05, 2023 0.7000 0.7200 0.5600 0.6000 0.6000 413,900
May 29, 2023 0.7100 0.7700 0.6900 0.7000 0.7000 357,600
May 22, 2023 0.7500 0.8000 0.6890 0.7050 0.7050 413,300
May 15, 2023 0.7700 0.7760 0.6440 0.7460 0.7460 420,900
May 08, 2023 0.7900 0.8680 0.7100 0.7520 0.7520 535,100
May 01, 2023 0.7600 0.8080 0.5500 0.7640 0.7640 1,197,700
Apr 24, 2023 0.9600 0.9930 0.7390 0.7940 0.7940 5,012,100
Apr 17, 2023 1.1400 1.2700 0.9340 0.9800 0.9800 2,665,500
Apr 10, 2023 1.2800 1.3000 1.0900 1.1400 1.1400 632,200
Apr 03, 2023 1.3400 1.3800 1.2900 1.3100 1.3100 512,800
Mar 27, 2023 1.5300 1.5600 1.1500 1.3300 1.3300 2,066,500
Mar 20, 2023 1.4800 1.6000 1.3100 1.4900 1.4900 2,480,700
Mar 13, 2023 1.0600 1.4700 0.9860 1.4700 1.4700 5,374,700
Mar 06, 2023 1.1100 1.2470 0.9300 1.1000 1.1000 3,861,800
Feb 27, 2023 1.0200 1.1300 1.0000 1.1000 1.1000 795,600
Feb 20, 2023 1.1800 1.2900 0.9900 1.0300 1.0300 1,145,700
Feb 13, 2023 1.4400 1.4400 0.9800 1.1800 1.1800 2,933,200
Feb 06, 2023 1.7600 2.0500 1.4000 1.4100 1.4100 4,334,900
Jan 30, 2023 1.9200 2.0800 1.6600 1.7400 1.7400 1,635,600
Jan 23, 2023 2.2700 2.3100 1.8200 1.9200 1.9200 2,118,100
Jan 16, 2023 2.6100 2.7210 2.2300 2.3000 2.3000 647,800
Jan 09, 2023 2.3900 2.7300 2.2200 2.6000 2.6000 1,294,300
Jan 02, 2023 2.8000 3.8000 2.5000 2.6500 2.6500 1,347,185
Dec 26, 2022 2.5800 3.2000 2.2200 2.8200 2.8200 505,600
Dec 19, 2022 2.8200 3.0000 2.4000 2.6000 2.6000 592,145
Dec 12, 2022 2.4200 9.0600 2.3400 2.6200 2.6200 13,543,83
OpGen, Inc. (OPGN) :0.6300+0.0600 (+10.53%)
52 Week Range 0.5400 - 13.6000
Following final assembly and successful testing, a batch of ten Unyvero A30 instrument systems has been received
Latest C-Series Unyvero A30 instruments optimized for series production and clinical trials
ROCKVILLE, Md., June 22, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported that its German subsidiary, Curetis GmbH, has received the full set of ten Unyvero A30 C-Series instruments, which have been assembled by its development partner, DMTPe, in Germany. The instruments have successfully passed electrical and functional testing and will allow rapid sample-to-answer molecular testing with numerous chemistries and assay formats.
These C-Series instruments incorporate all learnings from extensive testing of the 10 B-Series instruments over the past 12 months. The C-Series instruments have been optimized and improved for manufacturability, serviceability and robustness. They have also been optimized for extended lifetime of all key moving parts inside the instruments, as well as cost of goods in the manufacturing process of these A30 instruments.
Andreas Boos, CTO of Curetis and program lead of the Unyvero A30 platform project commented: “We are excited to have taken possession of this newest batch of instruments. With all of the improvements made to date, this is now very close to the final release version of the product. We intend to use the A30 C-Series instruments in all further product development and clinical trials as well as regulatory submissions for our application cartridges on the A30 system.” Mr. Boos added that, “all of our ten B-Series instruments have also been upgraded to this latest standard to plan for sufficient A30 instruments to be available for the continued development of our own assays and cartridges in house, and for collaborative projects such as the FIND R&D collaboration which aims to bring an A30 platform and antimicrobial resistance (AMR) test from blood cultures to low and middle income countries, as well as for other R&D collaboration projects funded by third party partners.”
About OpGen, Inc.
OpGen, Inc. (Rockville, MD, U.S.A.) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. Along with our subsidiaries, Curetis GmbH and Ares Genetics GmbH, we are developing and commercializing molecular microbiology solutions helping to guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs. OpGen’s current product portfolio includes Unyvero, Acuitas AMR Gene Panel, and the ARES Technology Platform including ARESdb, NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction including ARESiss, ARESid, ARESasp, and AREScloud, as well as the Curetis CE-IVD-marked PCR-based SARS-CoV-2 test kit.
For more information, please visit www.opgen.com.
time for a strong recovery:
Jun 21, 2023 0.5900 0.6300 0.5400 0.6300 0.6300 364,754
Jun 19, 2023 0.6000 0.6300 0.5400 0.6300 0.6300 527,300
Jun 12, 2023 0.6400 0.7200 0.5800 0.6000 0.6000 1,968,700
Jun 05, 2023 0.7000 0.7200 0.5600 0.6000 0.6000 413,900
May 29, 2023 0.7100 0.7700 0.6900 0.7000 0.7000 357,600
May 22, 2023 0.7500 0.8000 0.6890 0.7050 0.7050 413,300
May 15, 2023 0.7700 0.7760 0.6440 0.7460 0.7460 420,900
May 08, 2023 0.7900 0.8680 0.7100 0.7520 0.7520 535,100
May 01, 2023 0.7600 0.8080 0.5500 0.7640 0.7640 1,197,700
Apr 24, 2023 0.9600 0.9930 0.7390 0.7940 0.7940 5,012,100
Apr 17, 2023 1.1400 1.2700 0.9340 0.9800 0.9800 2,665,500
Apr 10, 2023 1.2800 1.3000 1.0900 1.1400 1.1400 632,200
Apr 03, 2023 1.3400 1.3800 1.2900 1.3100 1.3100 512,800
Mar 27, 2023 1.5300 1.5600 1.1500 1.3300 1.3300 2,066,500
Mar 20, 2023 1.4800 1.6000 1.3100 1.4900 1.4900 2,480,700
Mar 13, 2023 1.0600 1.4700 0.9860 1.4700 1.4700 5,374,700
Mar 06, 2023 1.1100 1.2470 0.9300 1.1000 1.1000 3,861,800
Feb 27, 2023 1.0200 1.1300 1.0000 1.1000 1.1000 795,600
Feb 20, 2023 1.1800 1.2900 0.9900 1.0300 1.0300 1,145,700
Feb 13, 2023 1.4400 1.4400 0.9800 1.1800 1.1800 2,933,200
Feb 06, 2023 1.7600 2.0500 1.4000 1.4100 1.4100 4,334,900
Jan 30, 2023 1.9200 2.0800 1.6600 1.7400 1.7400 1,635,600
Jan 23, 2023 2.2700 2.3100 1.8200 1.9200 1.9200 2,118,100
Jan 16, 2023 2.6100 2.7210 2.2300 2.3000 2.3000 647,800
Jan 09, 2023 2.3900 2.7300 2.2200 2.6000 2.6000 1,294,300
Jan 02, 2023 2.8000 3.8000 2.5000 2.6500 2.6500 1,347,185
Dec 26, 2022 2.5800 3.2000 2.2200 2.8200 2.8200 505,600
Dec 19, 2022 2.8200 3.0000 2.4000 2.6000 2.6000 592,145
Dec 12, 2022 2.4200 9.0600 2.3400 2.6200 2.6200 13,543,83
OpGen, Inc. (OPGN) :0.6300+0.0600 (+10.53%)
52 Week Range 0.5400 - 13.6000
Following final assembly and successful testing, a batch of ten Unyvero A30 instrument systems has been received
Latest C-Series Unyvero A30 instruments optimized for series production and clinical trials
ROCKVILLE, Md., June 22, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, “OpGen” or “the Company”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, reported that its German subsidiary, Curetis GmbH, has received the full set of ten Unyvero A30 C-Series instruments, which have been assembled by its development partner, DMTPe, in Germany. The instruments have successfully passed electrical and functional testing and will allow rapid sample-to-answer molecular testing with numerous chemistries and assay formats.
These C-Series instruments incorporate all learnings from extensive testing of the 10 B-Series instruments over the past 12 months. The C-Series instruments have been optimized and improved for manufacturability, serviceability and robustness. They have also been optimized for extended lifetime of all key moving parts inside the instruments, as well as cost of goods in the manufacturing process of these A30 instruments.
Andreas Boos, CTO of Curetis and program lead of the Unyvero A30 platform project commented: “We are excited to have taken possession of this newest batch of instruments. With all of the improvements made to date, this is now very close to the final release version of the product. We intend to use the A30 C-Series instruments in all further product development and clinical trials as well as regulatory submissions for our application cartridges on the A30 system.” Mr. Boos added that, “all of our ten B-Series instruments have also been upgraded to this latest standard to plan for sufficient A30 instruments to be available for the continued development of our own assays and cartridges in house, and for collaborative projects such as the FIND R&D collaboration which aims to bring an A30 platform and antimicrobial resistance (AMR) test from blood cultures to low and middle income countries, as well as for other R&D collaboration projects funded by third party partners.”
About OpGen, Inc.
OpGen, Inc. (Rockville, MD, U.S.A.) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. Along with our subsidiaries, Curetis GmbH and Ares Genetics GmbH, we are developing and commercializing molecular microbiology solutions helping to guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs. OpGen’s current product portfolio includes Unyvero, Acuitas AMR Gene Panel, and the ARES Technology Platform including ARESdb, NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction including ARESiss, ARESid, ARESasp, and AREScloud, as well as the Curetis CE-IVD-marked PCR-based SARS-CoV-2 test kit.
For more information, please visit www.opgen.com.
time for a strong recovery:
Jun 21, 2023 0.5900 0.6300 0.5400 0.6300 0.6300 364,754
Jun 19, 2023 0.6000 0.6300 0.5400 0.6300 0.6300 527,300
Jun 12, 2023 0.6400 0.7200 0.5800 0.6000 0.6000 1,968,700
Jun 05, 2023 0.7000 0.7200 0.5600 0.6000 0.6000 413,900
May 29, 2023 0.7100 0.7700 0.6900 0.7000 0.7000 357,600
May 22, 2023 0.7500 0.8000 0.6890 0.7050 0.7050 413,300
May 15, 2023 0.7700 0.7760 0.6440 0.7460 0.7460 420,900
May 08, 2023 0.7900 0.8680 0.7100 0.7520 0.7520 535,100
May 01, 2023 0.7600 0.8080 0.5500 0.7640 0.7640 1,197,700
Apr 24, 2023 0.9600 0.9930 0.7390 0.7940 0.7940 5,012,100
Apr 17, 2023 1.1400 1.2700 0.9340 0.9800 0.9800 2,665,500
Apr 10, 2023 1.2800 1.3000 1.0900 1.1400 1.1400 632,200
Apr 03, 2023 1.3400 1.3800 1.2900 1.3100 1.3100 512,800
Mar 27, 2023 1.5300 1.5600 1.1500 1.3300 1.3300 2,066,500
Mar 20, 2023 1.4800 1.6000 1.3100 1.4900 1.4900 2,480,700
Mar 13, 2023 1.0600 1.4700 0.9860 1.4700 1.4700 5,374,700
Mar 06, 2023 1.1100 1.2470 0.9300 1.1000 1.1000 3,861,800
Feb 27, 2023 1.0200 1.1300 1.0000 1.1000 1.1000 795,600
Feb 20, 2023 1.1800 1.2900 0.9900 1.0300 1.0300 1,145,700
Feb 13, 2023 1.4400 1.4400 0.9800 1.1800 1.1800 2,933,200
Feb 06, 2023 1.7600 2.0500 1.4000 1.4100 1.4100 4,334,900
Jan 30, 2023 1.9200 2.0800 1.6600 1.7400 1.7400 1,635,600
Jan 23, 2023 2.2700 2.3100 1.8200 1.9200 1.9200 2,118,100
Jan 16, 2023 2.6100 2.7210 2.2300 2.3000 2.3000 647,800
Jan 09, 2023 2.3900 2.7300 2.2200 2.6000 2.6000 1,294,300
Jan 02, 2023 2.8000 3.8000 2.5000 2.6500 2.6500 1,347,185
Dec 26, 2022 2.5800 3.2000 2.2200 2.8200 2.8200 505,600
Dec 19, 2022 2.8200 3.0000 2.4000 2.6000 2.6000 592,145
Dec 12, 2022 2.4200 9.0600 2.3400 2.6200 2.6200 13,543,83
TAOP: 0.71
52w: 0.55 - 1.75
SHENZHEN, China, June 20, 2023 /PRNewswire/ -- Taoping Inc. (NASDAQ: TAOP, the "Company" or "Taoping"), today announced the launch of the Company's AI-aided innovative new, rapid, off-grid wastewater treatment solutions designed to bring "Clean Water for a Cleaner World". The lower cost, portable wastewater treatment solutions represent a watershed moment in the global effort for a cleaner environment, and will be integrated with Taoping's intelligent operation and maintenance system aided by the Company's powerful new Cloud Nest AI system and intelligent Cloud platform to significantly increase operations and cost efficiencies of maintenance management.
(PRNewsfoto/Taoping Inc.)
(PRNewsfoto/Taoping Inc.)
Underserved rural markets will be a top priority for Taoping's new off-grid wastewater treatment solutions. The market size for wastewater treatment for the rural areas of China is estimated to be approximately RMB 300 billion in 2023, with a CAGR of 10% over the next 5 years. (source: Zhongtou Consultant)
The off-grid wastewater treatment solutions market refers to the market for wastewater treatment systems that operate without being connected to the grid. These systems are typically used in remote or rural areas where traditional wastewater treatment infrastructure is not available. The off-grid wastewater treatment solutions market is expected to grow in the coming years, driven by increasing demand from developing countries and remote areas.
Mr. Lin Jianghuai, Chairman and CEO of Taoping, said: "There is growing demand for off-grid wastewater treatment solutions due to several factors, including increasing population growth, urbanization, and environmental concerns. Additionally, the cost of traditional wastewater treatment infrastructure can be prohibitively expensive in remote areas, making off-grid solutions an attractive alternative. Taoping's purpose built wastewater treatment solutions provide a portable, on-site solution with lower upfront and maintenance costs, that leverages the advantages of traditional solutions, while offering highly compelling performance, Cloud-based monitoring, maintenance and cost advantages. More importantly, the Company's intelligent operation and maintenance system aided by Taoping's powerful new Cloud Nest AI system and intelligent Cloud platform can increase operations and cost efficiencies of maintenance management, truly realizing the automatic operation of sewage treatment facilities in low- and medium-density urban and rural residential areas, which we expect will make this a preferred choice that is more attractive to the market."
Mr. Lin continued: "We are very excited about the long-term opportunities for Taoping's wastewater treatment solutions. We are committed to helping customers and communities create a more sustainable future with Clean Water for a Cleaner World. We are taking a cyclical approach to managing wastewater that emphasizes the effectiveness of our innovative new wastewater treatment solutions, as we reinforce our commitment to both environmental sustainability and efficient wastewater management. We will continue to promote the deep integration of AI technology and sewage treatment products to build a new wastewater environment management integration platform with low cost, hassle free construction, intelligent operation and maintenance, convenient operation, and reduced cost of clear ownership to form valuable brand assets and drive the Company's revenue growth."
Off-grid wastewater treatment refers to the method of onsite wastewater treatment in the smallest unit of wastewater source as far as possible in the middle and low population density residential areas. For example, in individual farmers, B&Bs, villas, public toilets, schools, hospitals, hotels, residential communities, parks, urban villages, temporary construction sites, islands and other sources of domestic wastewater treatment after discharge or reuse standards. Taopping's off-grid wastewater treatment solutions are able to treat wastewater from a single source or multiple sources.
About Taoping Inc.
Taoping Inc. (Nasdaq: TAOP) has a long history of successfully leveraging technology in the development of innovative solutions to help customers in both the private and public sectors to more effectively communicate and market to their desired targets. The Company has built a far-reaching city partner ecosystem and comprehensive portfolio of high-value, high-traffic areas for its products, which are aligned together with Taoping's smart cloud platform, cloud services and solutions, new media and artificial intelligence. For more information about Taoping, please visit www.taop.com. You can also follow us via LinkedIn, Twitter or YouTube.
TAOP: 0.71
52w: 0.55 - 1.75
SHENZHEN, China, June 20, 2023 /PRNewswire/ -- Taoping Inc. (NASDAQ: TAOP, the "Company" or "Taoping"), today announced the launch of the Company's AI-aided innovative new, rapid, off-grid wastewater treatment solutions designed to bring "Clean Water for a Cleaner World". The lower cost, portable wastewater treatment solutions represent a watershed moment in the global effort for a cleaner environment, and will be integrated with Taoping's intelligent operation and maintenance system aided by the Company's powerful new Cloud Nest AI system and intelligent Cloud platform to significantly increase operations and cost efficiencies of maintenance management.
(PRNewsfoto/Taoping Inc.)
(PRNewsfoto/Taoping Inc.)
Underserved rural markets will be a top priority for Taoping's new off-grid wastewater treatment solutions. The market size for wastewater treatment for the rural areas of China is estimated to be approximately RMB 300 billion in 2023, with a CAGR of 10% over the next 5 years. (source: Zhongtou Consultant)
The off-grid wastewater treatment solutions market refers to the market for wastewater treatment systems that operate without being connected to the grid. These systems are typically used in remote or rural areas where traditional wastewater treatment infrastructure is not available. The off-grid wastewater treatment solutions market is expected to grow in the coming years, driven by increasing demand from developing countries and remote areas.
Mr. Lin Jianghuai, Chairman and CEO of Taoping, said: "There is growing demand for off-grid wastewater treatment solutions due to several factors, including increasing population growth, urbanization, and environmental concerns. Additionally, the cost of traditional wastewater treatment infrastructure can be prohibitively expensive in remote areas, making off-grid solutions an attractive alternative. Taoping's purpose built wastewater treatment solutions provide a portable, on-site solution with lower upfront and maintenance costs, that leverages the advantages of traditional solutions, while offering highly compelling performance, Cloud-based monitoring, maintenance and cost advantages. More importantly, the Company's intelligent operation and maintenance system aided by Taoping's powerful new Cloud Nest AI system and intelligent Cloud platform can increase operations and cost efficiencies of maintenance management, truly realizing the automatic operation of sewage treatment facilities in low- and medium-density urban and rural residential areas, which we expect will make this a preferred choice that is more attractive to the market."
Mr. Lin continued: "We are very excited about the long-term opportunities for Taoping's wastewater treatment solutions. We are committed to helping customers and communities create a more sustainable future with Clean Water for a Cleaner World. We are taking a cyclical approach to managing wastewater that emphasizes the effectiveness of our innovative new wastewater treatment solutions, as we reinforce our commitment to both environmental sustainability and efficient wastewater management. We will continue to promote the deep integration of AI technology and sewage treatment products to build a new wastewater environment management integration platform with low cost, hassle free construction, intelligent operation and maintenance, convenient operation, and reduced cost of clear ownership to form valuable brand assets and drive the Company's revenue growth."
Off-grid wastewater treatment refers to the method of onsite wastewater treatment in the smallest unit of wastewater source as far as possible in the middle and low population density residential areas. For example, in individual farmers, B&Bs, villas, public toilets, schools, hospitals, hotels, residential communities, parks, urban villages, temporary construction sites, islands and other sources of domestic wastewater treatment after discharge or reuse standards. Taopping's off-grid wastewater treatment solutions are able to treat wastewater from a single source or multiple sources.
About Taoping Inc.
Taoping Inc. (Nasdaq: TAOP) has a long history of successfully leveraging technology in the development of innovative solutions to help customers in both the private and public sectors to more effectively communicate and market to their desired targets. The Company has built a far-reaching city partner ecosystem and comprehensive portfolio of high-value, high-traffic areas for its products, which are aligned together with Taoping's smart cloud platform, cloud services and solutions, new media and artificial intelligence. For more information about Taoping, please visit www.taop.com. You can also follow us via LinkedIn, Twitter or YouTube.
voxeljet AG (VJET)
2.0300+0.0900 (+4.64%)
At close: June 16 03:59PM EDT
Premarket: 2.4700 +0.44 (+22.11%)
voxeljet AG provides three-dimensional (3D) printers and on-demand parts services to industrial and commercial customers in Europe, the Middle East, Africa, the Asia Pacific, and the Americas. The company operates in two segments, Systems and Services. The Systems segment develops, manufactures, and sells 3D printers. This segment also offers consumables, including particulate materials, proprietary chemical binding agents, and spare parts, as well as maintenance contracts. The Services segment prints on-demand parts for its customers, as well as creates parts, molds, cores, and models based on designs produced using 3D computer-aided design software; and provides casting services. It serves automotive, aerospace, art and architecture, engineering, and consumer product end markets; foundries and suppliers; and universities and research institutes. The company was formerly known as Voxeljet Technology GmbH and changed its name to voxeljet AG in January 2004. voxeljet AG was founded in 1999 and is headquartered in Friedberg, Germany.
Jun 16, 2023 2.0100 2.0700 1.8900 2.0300 2.0300 369,486
Jun 01, 2023 2.0500 2.2900 1.8100 1.9900 1.9900 970,600
May 01, 2023 1.9300 2.0500 1.7700 1.9500 1.9500 187,800
Apr 01, 2023 2.1000 2.2000 1.8900 1.9700 1.9700 208,200
Mar 01, 2023 2.3400 2.5200 1.9500 2.1100 2.1100 339,700
Feb 01, 2023 2.3800 2.8300 2.3300 2.3800 2.3800 191,100
Jan 01, 2023 2.3500 2.5200 2.0500 2.3200 2.3200 323,300
Dec 01, 2022 2.6400 2.9500 2.0200 2.3000 2.3000 414,500
Nov 01, 2022 2.9700 3.4000 2.4200 2.6400 2.6400 410,100
Oct 01, 2022 3.2500 3.9600 2.5500 3.0000 3.0000 485,600
Sep 01, 2022 4.8000 5.4300 3.0900 3.1500 3.1500 315,600
Aug 01, 2022 4.1400 7.2500 4.0200 4.7900 4.7900 1,523,800
Jul 01, 2022 3.2600 4.2600 3.2500 3.9500 3.9500 212,700
Jun 01, 2022 4.2800 4.3300 3.1100 3.3800 3.3800 157,100
May 01, 2022 4.3500 4.5600 3.7800 4.0300 4.0300 208,300
Apr 01, 2022 4.3000 4.6500 3.8500 4.4100 4.4100 243,400
Mar 01, 2022 4.2000 5.0000 3.8600 4.2700 4.2700 541,900
Feb 01, 2022 5.8400 7.4500 3.6300 4.0000 4.0000 833,600
Jan 01, 2022 5.9400 6.9000 4.7000 5.7500 5.7500 439,500
Dec 01, 2021 7.5900 7.8500 5.4400 5.9000 5.9000 766,000
Nov 01, 2021 9.0000 9.8600 7.1200 7.4900 7.4900 667,300
Oct 01, 2021 8.9400 10.0000 8.1100 8.9700 8.9700 773,600
Sep 01, 2021 7.2200 9.1400 6.9500 9.1400 9.1400 848,900
Aug 01, 2021 9.1200 10.1400 6.7500 7.2500 7.2500 2,150,200
Jul 01, 2021 13.1700 15.4600 8.2600 8.9200 8.9200 1,891,300
Jun 01, 2021 15.2300 15.4400 12.6200 12.7900 12.7900 521,400
May 01, 2021 15.0000 15.2500 11.4000 14.9200 14.9200 604,900
Apr 01, 2021 15.1500 16.6300 13.0000 14.7300 14.7300 1,222,600
Mar 01, 2021 17.3400 19.8300 11.8800 15.6000 15.6000 2,587,300
Feb 01, 2021 14.3000 40.0000 14.3000 17.0000 17.0000 5,127,800
voxeljet AG (VJET)
2.0300+0.0900 (+4.64%)
At close: June 16 03:59PM EDT
Premarket: 2.4700 +0.44 (+22.11%)
voxeljet AG provides three-dimensional (3D) printers and on-demand parts services to industrial and commercial customers in Europe, the Middle East, Africa, the Asia Pacific, and the Americas. The company operates in two segments, Systems and Services. The Systems segment develops, manufactures, and sells 3D printers. This segment also offers consumables, including particulate materials, proprietary chemical binding agents, and spare parts, as well as maintenance contracts. The Services segment prints on-demand parts for its customers, as well as creates parts, molds, cores, and models based on designs produced using 3D computer-aided design software; and provides casting services. It serves automotive, aerospace, art and architecture, engineering, and consumer product end markets; foundries and suppliers; and universities and research institutes. The company was formerly known as Voxeljet Technology GmbH and changed its name to voxeljet AG in January 2004. voxeljet AG was founded in 1999 and is headquartered in Friedberg, Germany.
Jun 16, 2023 2.0100 2.0700 1.8900 2.0300 2.0300 369,486
Jun 01, 2023 2.0500 2.2900 1.8100 1.9900 1.9900 970,600
May 01, 2023 1.9300 2.0500 1.7700 1.9500 1.9500 187,800
Apr 01, 2023 2.1000 2.2000 1.8900 1.9700 1.9700 208,200
Mar 01, 2023 2.3400 2.5200 1.9500 2.1100 2.1100 339,700
Feb 01, 2023 2.3800 2.8300 2.3300 2.3800 2.3800 191,100
Jan 01, 2023 2.3500 2.5200 2.0500 2.3200 2.3200 323,300
Dec 01, 2022 2.6400 2.9500 2.0200 2.3000 2.3000 414,500
Nov 01, 2022 2.9700 3.4000 2.4200 2.6400 2.6400 410,100
Oct 01, 2022 3.2500 3.9600 2.5500 3.0000 3.0000 485,600
Sep 01, 2022 4.8000 5.4300 3.0900 3.1500 3.1500 315,600
Aug 01, 2022 4.1400 7.2500 4.0200 4.7900 4.7900 1,523,800
Jul 01, 2022 3.2600 4.2600 3.2500 3.9500 3.9500 212,700
Jun 01, 2022 4.2800 4.3300 3.1100 3.3800 3.3800 157,100
May 01, 2022 4.3500 4.5600 3.7800 4.0300 4.0300 208,300
Apr 01, 2022 4.3000 4.6500 3.8500 4.4100 4.4100 243,400
Mar 01, 2022 4.2000 5.0000 3.8600 4.2700 4.2700 541,900
Feb 01, 2022 5.8400 7.4500 3.6300 4.0000 4.0000 833,600
Jan 01, 2022 5.9400 6.9000 4.7000 5.7500 5.7500 439,500
Dec 01, 2021 7.5900 7.8500 5.4400 5.9000 5.9000 766,000
Nov 01, 2021 9.0000 9.8600 7.1200 7.4900 7.4900 667,300
Oct 01, 2021 8.9400 10.0000 8.1100 8.9700 8.9700 773,600
Sep 01, 2021 7.2200 9.1400 6.9500 9.1400 9.1400 848,900
Aug 01, 2021 9.1200 10.1400 6.7500 7.2500 7.2500 2,150,200
Jul 01, 2021 13.1700 15.4600 8.2600 8.9200 8.9200 1,891,300
Jun 01, 2021 15.2300 15.4400 12.6200 12.7900 12.7900 521,400
May 01, 2021 15.0000 15.2500 11.4000 14.9200 14.9200 604,900
Apr 01, 2021 15.1500 16.6300 13.0000 14.7300 14.7300 1,222,600
Mar 01, 2021 17.3400 19.8300 11.8800 15.6000 15.6000 2,587,300
Feb 01, 2021 14.3000 40.0000 14.3000 17.0000 17.0000 5,127,800
voxeljet AG (VJET)
2.0300+0.0900 (+4.64%)
At close: June 16 03:59PM EDT
Premarket: 2.2600 +0.27 (+13.57%)
voxeljet AG provides three-dimensional (3D) printers and on-demand parts services to industrial and commercial customers in Europe, the Middle East, Africa, the Asia Pacific, and the Americas. The company operates in two segments, Systems and Services. The Systems segment develops, manufactures, and sells 3D printers. This segment also offers consumables, including particulate materials, proprietary chemical binding agents, and spare parts, as well as maintenance contracts. The Services segment prints on-demand parts for its customers, as well as creates parts, molds, cores, and models based on designs produced using 3D computer-aided design software; and provides casting services. It serves automotive, aerospace, art and architecture, engineering, and consumer product end markets; foundries and suppliers; and universities and research institutes. The company was formerly known as Voxeljet Technology GmbH and changed its name to voxeljet AG in January 2004. voxeljet AG was founded in 1999 and is headquartered in Friedberg, Germany.
Jun 16, 2023 2.0100 2.0700 1.8900 2.0300 2.0300 369,486
Jun 01, 2023 2.0500 2.2900 1.8100 1.9900 1.9900 970,600
May 01, 2023 1.9300 2.0500 1.7700 1.9500 1.9500 187,800
Apr 01, 2023 2.1000 2.2000 1.8900 1.9700 1.9700 208,200
Mar 01, 2023 2.3400 2.5200 1.9500 2.1100 2.1100 339,700
Feb 01, 2023 2.3800 2.8300 2.3300 2.3800 2.3800 191,100
Jan 01, 2023 2.3500 2.5200 2.0500 2.3200 2.3200 323,300
Dec 01, 2022 2.6400 2.9500 2.0200 2.3000 2.3000 414,500
Nov 01, 2022 2.9700 3.4000 2.4200 2.6400 2.6400 410,100
Oct 01, 2022 3.2500 3.9600 2.5500 3.0000 3.0000 485,600
Sep 01, 2022 4.8000 5.4300 3.0900 3.1500 3.1500 315,600
Aug 01, 2022 4.1400 7.2500 4.0200 4.7900 4.7900 1,523,800
Jul 01, 2022 3.2600 4.2600 3.2500 3.9500 3.9500 212,700
Jun 01, 2022 4.2800 4.3300 3.1100 3.3800 3.3800 157,100
May 01, 2022 4.3500 4.5600 3.7800 4.0300 4.0300 208,300
Apr 01, 2022 4.3000 4.6500 3.8500 4.4100 4.4100 243,400
Mar 01, 2022 4.2000 5.0000 3.8600 4.2700 4.2700 541,900
Feb 01, 2022 5.8400 7.4500 3.6300 4.0000 4.0000 833,600
Jan 01, 2022 5.9400 6.9000 4.7000 5.7500 5.7500 439,500
Dec 01, 2021 7.5900 7.8500 5.4400 5.9000 5.9000 766,000
Nov 01, 2021 9.0000 9.8600 7.1200 7.4900 7.4900 667,300
Oct 01, 2021 8.9400 10.0000 8.1100 8.9700 8.9700 773,600
Sep 01, 2021 7.2200 9.1400 6.9500 9.1400 9.1400 848,900
Aug 01, 2021 9.1200 10.1400 6.7500 7.2500 7.2500 2,150,200
Jul 01, 2021 13.1700 15.4600 8.2600 8.9200 8.9200 1,891,300
Jun 01, 2021 15.2300 15.4400 12.6200 12.7900 12.7900 521,400
May 01, 2021 15.0000 15.2500 11.4000 14.9200 14.9200 604,900
Apr 01, 2021 15.1500 16.6300 13.0000 14.7300 14.7300 1,222,600
Mar 01, 2021 17.3400 19.8300 11.8800 15.6000 15.6000 2,587,300
Feb 01, 2021 14.3000 40.0000 14.3000 17.0000 17.0000 5,127,800
ATERIAN (ATER) : 0.5594
52w : 0.45 – 3.58
https://www.aterian.io/
Aterian, Inc. is a technology-enabled consumer product company, which builds, acquires, and partners with e-commerce brands. It uses data science, which includes machine learning, natural language processing, and data analytics to design, develop, market, and sell products. Its data science-based software technology platform, AIMEE is a cloud-based modular platform incorporating a multi-tenant architecture. AIMEE connects to multiple e-commerce platforms and other Internet-based sources through application program interfaces in order to ingest data. It owns and operates 15 brands which sell products in multiple categories, including home and kitchen appliances, kitchenware, heating, cooling and air quality appliances (dehumidifiers, humidifiers, and air conditioners), health and beauty products. Its brands include hOmeLabs; Vremi, Squatty Potty; RIF6; Aussie Health; Holonix; Truweo; Pursteam; Pohl and Schmitt; Spiralizer; Healing Solutions, and Photo Paper Direct and Step and Go.
Shares Outstanding 81.63M
Float 60.38M
Shares Short (May 30, 2023) 7.34M
Short % of Float (May 30, 2023) 9.35%
Total Cash (mrq) 33.91M
Total Cash Per Share (mrq) 0.44
Book Value Per Share (mrq) 1.03
ATERIAN (ATER) : 0.5594
52w : 0.45 – 3.58
https://www.aterian.io/
Aterian, Inc. is a technology-enabled consumer product company, which builds, acquires, and partners with e-commerce brands. It uses data science, which includes machine learning, natural language processing, and data analytics to design, develop, market, and sell products. Its data science-based software technology platform, AIMEE is a cloud-based modular platform incorporating a multi-tenant architecture. AIMEE connects to multiple e-commerce platforms and other Internet-based sources through application program interfaces in order to ingest data. It owns and operates 15 brands which sell products in multiple categories, including home and kitchen appliances, kitchenware, heating, cooling and air quality appliances (dehumidifiers, humidifiers, and air conditioners), health and beauty products. Its brands include hOmeLabs; Vremi, Squatty Potty; RIF6; Aussie Health; Holonix; Truweo; Pursteam; Pohl and Schmitt; Spiralizer; Healing Solutions, and Photo Paper Direct and Step and Go.
Shares Outstanding 81.63M
Float 60.38M
Shares Short (May 30, 2023) 7.34M
Short % of Float (May 30, 2023) 9.35%
Total Cash (mrq) 33.91M
Total Cash Per Share (mrq) 0.44
Book Value Per Share (mrq) 1.03
0.4034+0.0034 (+0.85%)
BEIJING, June 7, 2023 /PRNewswire/ -- Recon Technology, Ltd (NASDAQ: RCON) ("Recon" or the "Company") today announced that Nanjing Recon Technology Co., Ltd ("Nanjing Recon") has been awarded a contract worth RMB 6,104,000 (or USD 1.0 million) for the Ground Control Project in the Deep Shale Gas Field at a Well Area in Chongqing City located in mainland China.
The Company will commence the project upon contract execution and expects to complete services no later than December 31, 2024.
Under the terms of the contract, Nanjing Recon will implement the Ground Control Project, which focuses on the autonomous monitoring and control system for the deep shale gas field. This project marks another significant milestone for Recon, and further solidifying its position as a key player in providing innovative solutions to the oil and gas industry in China.
"We are very pleased to have been awarded this contract for the ground control project in the deep shale gas field," said Mr. Shenping Yin, Founder and CEO of Recon Technology. "This project underscores our commitment to providing cutting-edge technologies and solutions that enhance operational efficiency and safety in the oil and gas sector. We are confident that our expertise and experience will contribute to the success of the project and further strengthen our prominent position in the industry."
The deep shale gas field at the well site has immense potential for the development of shale gas resources. Recon's advanced autonomous monitoring and control solution will play a critical role in optimizing production processes, ensuring environmental protection, and maximizing the efficiency of deep shale gas productions.
Recon Technology will now proceed to finalize the contract. The company is committed to delivering the project to the highest standards and within the agreed timeframe.
About Recon Technology, Ltd ("RCON")
Recon Technology, Ltd (NASDAQ: RCON) is the People's Republic of China's first NASDAQ-listed non-state owned oil and gas field service company. Recon supplies China's largest oil exploration companies, Sinopec (NYSE: SNP) and The China National Petroleum Corporation ("CNPC"), with advanced automated technologies, efficient gathering and transportation equipment and reservoir stimulation measure for increasing petroleum extraction levels, reducing impurities and lowering production costs. Through the years, RCON has taken leading positions within several segmented markets of the oil and gas filed service industry. RCON also has developed stable long-term cooperation relationship with its major clients. For additional information please visit: http://www.recon.cn/. Nanjing Recon is a variable interest entity of Recon Hengda Technology (Beijing) Co., Ltd., a mainland China subsidiary of Recon.
RCON: 0.4034+0.0034 (+0.85%)
BEIJING, June 7, 2023 /PRNewswire/ -- Recon Technology, Ltd (NASDAQ: RCON) ("Recon" or the "Company") today announced that Nanjing Recon Technology Co., Ltd ("Nanjing Recon") has been awarded a contract worth RMB 6,104,000 (or USD 1.0 million) for the Ground Control Project in the Deep Shale Gas Field at a Well Area in Chongqing City located in mainland China.
The Company will commence the project upon contract execution and expects to complete services no later than December 31, 2024.
Under the terms of the contract, Nanjing Recon will implement the Ground Control Project, which focuses on the autonomous monitoring and control system for the deep shale gas field. This project marks another significant milestone for Recon, and further solidifying its position as a key player in providing innovative solutions to the oil and gas industry in China.
"We are very pleased to have been awarded this contract for the ground control project in the deep shale gas field," said Mr. Shenping Yin, Founder and CEO of Recon Technology. "This project underscores our commitment to providing cutting-edge technologies and solutions that enhance operational efficiency and safety in the oil and gas sector. We are confident that our expertise and experience will contribute to the success of the project and further strengthen our prominent position in the industry."
The deep shale gas field at the well site has immense potential for the development of shale gas resources. Recon's advanced autonomous monitoring and control solution will play a critical role in optimizing production processes, ensuring environmental protection, and maximizing the efficiency of deep shale gas productions.
Recon Technology will now proceed to finalize the contract. The company is committed to delivering the project to the highest standards and within the agreed timeframe.
About Recon Technology, Ltd ("RCON")
Recon Technology, Ltd (NASDAQ: RCON) is the People's Republic of China's first NASDAQ-listed non-state owned oil and gas field service company. Recon supplies China's largest oil exploration companies, Sinopec (NYSE: SNP) and The China National Petroleum Corporation ("CNPC"), with advanced automated technologies, efficient gathering and transportation equipment and reservoir stimulation measure for increasing petroleum extraction levels, reducing impurities and lowering production costs. Through the years, RCON has taken leading positions within several segmented markets of the oil and gas filed service industry. RCON also has developed stable long-term cooperation relationship with its major clients. For additional information please visit: http://www.recon.cn/. Nanjing Recon is a variable interest entity of Recon Hengda Technology (Beijing) Co., Ltd., a mainland China subsidiary of Recon.
TAOPING (TAOP) : 0,749899 +7,13%
SHENZHEN, China, June 6, 2023 /PRNewswire/ -- Taoping Inc. (NASDAQ: TAOP, the "Company" or "Taoping"), today announced that the Company secured another RMB 10 million (approximately US$1.4 million) contract to supply its innovative Smart Rest Stations, autonomous cleaning robots, and other related products and services to Shenzhen Huaqi Technology Co., Ltd. (Huaqi). The latest RMB 10 million contract with Huaqi follows May 1, 2023 news of Taoping's RMB 11 million contract from Beijing Huida Dianjian Technology Co., Ltd., and reflects the increased business momentum the Company is benefitting from.
Founded in 2016, Huaqi is a high-tech company engaged in generative AI visual related products and services. Under the agreement, initial deliveries to Huaqi are expected to commence over the next few weeks, with the full order being completed over the coming quarters.
This latest contract win underscores the increased demand and long-term potential for the Taoping's innovative Smart Rest Station products and services. The contract is structured along the same lines as earlier agreements for Taoping's next-generation Smart Rest Station, integrated with its fully autonomous cleaning robots, as well as supporting servers, logistics, installation, and commissioning services. By offering a comprehensive range of innovative and scalable products and services, Taoping believes it is well-positioned to fulfill a growing share of the increasing opportunities for smart city technologies and infrastructure improvements in China.
Mr. Lin Jianghuai, Chairman and CEO of Taoping, said: "We are thrilled to announce our latest partnership with Huaqi, which further validates the growing recognition and demand for our innovative and end-to-end Smart Rest Station solutions. There is an urgent need for more efficient, eco-friendly, and cost-effective solutions, and we are proud to deliver just that. In addition to helping to significantly enhance the efficiency of urban infrastructure and environmental protection initiatives in some of China's most critical cities, by partnering together we help increase the economic robustness and desirability for businesses and residents. This in turn, helps create significant value."
About Taoping Inc.
Taoping Inc. (Nasdaq: TAOP) has a long history of successfully leveraging technology in the development of innovative solutions to help customers in both the private and public sectors to more effectively communicate and market to their desired targets. The Company has built a far-reaching city partner ecosystem and comprehensive portfolio of high-value, high-traffic areas for its products, which are aligned together with Taoping's smart cloud platform, cloud services and solutions, new media and artificial intelligence. For more information about Taoping, please visit www.taop.com. You can also follow us via LinkedIn, Twitter or YouTube.
TAOPING (TAOP) : 0,749899 +7,13%
SHENZHEN, China, June 6, 2023 /PRNewswire/ -- Taoping Inc. (NASDAQ: TAOP, the "Company" or "Taoping"), today announced that the Company secured another RMB 10 million (approximately US$1.4 million) contract to supply its innovative Smart Rest Stations, autonomous cleaning robots, and other related products and services to Shenzhen Huaqi Technology Co., Ltd. (Huaqi). The latest RMB 10 million contract with Huaqi follows May 1, 2023 news of Taoping's RMB 11 million contract from Beijing Huida Dianjian Technology Co., Ltd., and reflects the increased business momentum the Company is benefitting from.
(PRNewsfoto/Taoping Inc.)
(PRNewsfoto/Taoping Inc.)
Founded in 2016, Huaqi is a high-tech company engaged in generative AI visual related products and services. Under the agreement, initial deliveries to Huaqi are expected to commence over the next few weeks, with the full order being completed over the coming quarters.
This latest contract win underscores the increased demand and long-term potential for the Taoping's innovative Smart Rest Station products and services. The contract is structured along the same lines as earlier agreements for Taoping's next-generation Smart Rest Station, integrated with its fully autonomous cleaning robots, as well as supporting servers, logistics, installation, and commissioning services. By offering a comprehensive range of innovative and scalable products and services, Taoping believes it is well-positioned to fulfill a growing share of the increasing opportunities for smart city technologies and infrastructure improvements in China.
Mr. Lin Jianghuai, Chairman and CEO of Taoping, said: "We are thrilled to announce our latest partnership with Huaqi, which further validates the growing recognition and demand for our innovative and end-to-end Smart Rest Station solutions. There is an urgent need for more efficient, eco-friendly, and cost-effective solutions, and we are proud to deliver just that. In addition to helping to significantly enhance the efficiency of urban infrastructure and environmental protection initiatives in some of China's most critical cities, by partnering together we help increase the economic robustness and desirability for businesses and residents. This in turn, helps create significant value."
About Taoping Inc.
Taoping Inc. (Nasdaq: TAOP) has a long history of successfully leveraging technology in the development of innovative solutions to help customers in both the private and public sectors to more effectively communicate and market to their desired targets. The Company has built a far-reaching city partner ecosystem and comprehensive portfolio of high-value, high-traffic areas for its products, which are aligned together with Taoping's smart cloud platform, cloud services and solutions, new media and artificial intelligence. For more information about Taoping, please visit www.taop.com. You can also follow us via LinkedIn, Twitter or YouTube.
Herborium Group, Inc. (OTC:HBRM) is a botanical therapeutics® company that addresses dermatological and other health and wellness concerns via its proprietary medicinal products that are supported by science-centered content.
In an exclusive interview with the Capital Gains Report, HBRM CEO Dr. Agnes Olszewski discussed the company’s track to take advantage of promising opportunities arising in the natural segment of the wellness industry, particularly as it applies to skincare, and an important boost to this area of the market can get from the application of artificial intelligence.
HBRM’s Approach of Integrating Medicine and Beauty
The global natural cosmetics market is growing at a fast pace and is projected to reach $79.6 billion by 2033, with an annual growth rate of 5.1%. This rise is driven by the emergence of a new category of advanced, natural ingredient-based products available via conventional retail channels and online retailers, as well as the growing prominence of safer and more efficacious science-based beauty and wellness culture, which fuels the accelerated demand for natural beauty products.
Dr. Olszewski said, “One of the most important trends in the healthcare and beauty sectors is the merger of clinical skincare with natural skincare to create safe and validated “hybrid” products that actually work while maintaining their natural ingredient profile.”
Herborium’s acne treatment represents such a unique product. AcnEase is a systemic, all botanical ingredient-based, proprietary, clinically tested acne treatment for teen and adult acne, that also improves symptoms of an inflammatory skin condition called rosacea.
Dr. Olszewski said, “We are presently working on the second generation of this clinically validated skincare solution that has better consumer characteristics -- broader application and simpler treatment routine -- and improved business profile, such as increased margins. The company is also approaching the most advanced science in clinical skincare - stem cell-based products. We are working to add two highly innovative products in this category to our 2023 and 2024 product portfolios.”
The company pursues a cross-sectoral approach, aiming to use clinical testing in order to integrate pharmaceutical and nutraceutical market segments.
Exploring the Power of Artificial Intelligence in Natural Skincare Sector
Another strength of HBRM has to do with the use of pioneering technology as applied to the development of natural skincare products and a total solution that would address consumer concerns in the skincare sector. On May 11, 2023, the company announced signing a Letter of Intent with Adrecom, a US-based technology and e-commerce company with offices in North Carolina and California, to purchase and further advance AI technology that will power HBRM's natural skin health and wellness platform. It completed the first stage of designing this platform and is currently in the midst of testing and further advancing it.
Dr. Olszewski says, “Herborium’s unique approach is the active use of technology in the natural segment of skincare and skin wellness.” The AI platform will deliver streamlined and more precise diagnosis, curated, personalized skincare counseling, products, and other related services such as nutrition and esthetician-provided recommendations.
This step positions HBRM as a frontrunner in the novel skincare industry, opening up new ways for innovation and potential revenue streams. “Our AI-based platform offers an integrated, personalized approach to skincare and skin health,” says Dr. Olszewski. “At the moment, an integrated platform for natural skincare and skin wellness does not exist.”
As medicine and wellness develop in parallel with advancements in using AI technology to support a personalized approach to treatments and more common wellness and beauty solutions, HBRM is a first mover in this space as it is capable of combining its natural ingredient-based products and relevant, cutting edge content with advanced AI technology.
Growth through Partnerships
HBRM is currently commercializing its products and has already established a strong presence in the United States, the United Kingdom, and continental Europe through a network of specialty retailers, distributors, and e-commerce platforms.
With a well-established customer base and strong brand recognition, the company plans to establish new sales targets by building curated partnerships with other product originators. “We are presently in advanced talks with two companies—one from the US and a second from South Korea that are well known in the cosmetic and skin wellness industry for high-quality biotechnological applications in skincare,” says Dr. Olszewski.
Conclusion
Natural ingredients and the potential for an AI-driven personalized approach to skincare mean that Herborium’s products have the potential to gain popularity with consumers quickly. They are capable of connecting medical and beauty applications with a focus on natural ingredients, filling an important gap in the market.
Disclaimers: CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) has been retained by Herborium to assist in the production and distribution of content. 'CGR' is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR is not a fiduciary by virtue of any persons use of or access to this content.
Contact Details
Mark McKelvie
+1 585-301-7700
markrmckelvie@gmail.com
Company Website
http://Capitalgainsreport.com
HERBORIUM GROUP INC. (HBRM) : 0.0002
New York, NY --News Direct-- HBRM
Herborium Group, Inc. (OTC:HBRM) is a botanical therapeutics® company that addresses dermatological and other health and wellness concerns via its proprietary medicinal products that are supported by science-centered content.
In an exclusive interview with the Capital Gains Report, HBRM CEO Dr. Agnes Olszewski discussed the company’s track to take advantage of promising opportunities arising in the natural segment of the wellness industry, particularly as it applies to skincare, and an important boost to this area of the market can get from the application of artificial intelligence.
HBRM’s Approach of Integrating Medicine and Beauty
The global natural cosmetics market is growing at a fast pace and is projected to reach $79.6 billion by 2033, with an annual growth rate of 5.1%. This rise is driven by the emergence of a new category of advanced, natural ingredient-based products available via conventional retail channels and online retailers, as well as the growing prominence of safer and more efficacious science-based beauty and wellness culture, which fuels the accelerated demand for natural beauty products.
Dr. Olszewski said, “One of the most important trends in the healthcare and beauty sectors is the merger of clinical skincare with natural skincare to create safe and validated “hybrid” products that actually work while maintaining their natural ingredient profile.”
Herborium’s acne treatment represents such a unique product. AcnEase is a systemic, all botanical ingredient-based, proprietary, clinically tested acne treatment for teen and adult acne, that also improves symptoms of an inflammatory skin condition called rosacea.
Dr. Olszewski said, “We are presently working on the second generation of this clinically validated skincare solution that has better consumer characteristics -- broader application and simpler treatment routine -- and improved business profile, such as increased margins. The company is also approaching the most advanced science in clinical skincare - stem cell-based products. We are working to add two highly innovative products in this category to our 2023 and 2024 product portfolios.”
The company pursues a cross-sectoral approach, aiming to use clinical testing in order to integrate pharmaceutical and nutraceutical market segments.
Exploring the Power of Artificial Intelligence in Natural Skincare Sector
Another strength of HBRM has to do with the use of pioneering technology as applied to the development of natural skincare products and a total solution that would address consumer concerns in the skincare sector. On May 11, 2023, the company announced signing a Letter of Intent with Adrecom, a US-based technology and e-commerce company with offices in North Carolina and California, to purchase and further advance AI technology that will power HBRM's natural skin health and wellness platform. It completed the first stage of designing this platform and is currently in the midst of testing and further advancing it.
Dr. Olszewski says, “Herborium’s unique approach is the active use of technology in the natural segment of skincare and skin wellness.” The AI platform will deliver streamlined and more precise diagnosis, curated, personalized skincare counseling, products, and other related services such as nutrition and esthetician-provided recommendations.
This step positions HBRM as a frontrunner in the novel skincare industry, opening up new ways for innovation and potential revenue streams. “Our AI-based platform offers an integrated, personalized approach to skincare and skin health,” says Dr. Olszewski. “At the moment, an integrated platform for natural skincare and skin wellness does not exist.”
As medicine and wellness develop in parallel with advancements in using AI technology to support a personalized approach to treatments and more common wellness and beauty solutions, HBRM is a first mover in this space as it is capable of combining its natural ingredient-based products and relevant, cutting edge content with advanced AI technology.
Growth through Partnerships
HBRM is currently commercializing its products and has already established a strong presence in the United States, the United Kingdom, and continental Europe through a network of specialty retailers, distributors, and e-commerce platforms.
With a well-established customer base and strong brand recognition, the company plans to establish new sales targets by building curated partnerships with other product originators. “We are presently in advanced talks with two companies—one from the US and a second from South Korea that are well known in the cosmetic and skin wellness industry for high-quality biotechnological applications in skincare,” says Dr. Olszewski.
Conclusion
Natural ingredients and the potential for an AI-driven personalized approach to skincare mean that Herborium’s products have the potential to gain popularity with consumers quickly. They are capable of connecting medical and beauty applications with a focus on natural ingredients, filling an important gap in the market.
Disclaimers: CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) has been retained by Herborium to assist in the production and distribution of content. 'CGR' is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR is not a fiduciary by virtue of any persons use of or access to this content.
Contact Details
Mark McKelvie
+1 585-301-7700
markrmckelvie@gmail.com
Company Website
http://Capitalgainsreport.com
HERBORIUM GROUP INC. (HBRM) : 0.0002
New York, NY --News Direct-- HBRM
Herborium Group, Inc. (OTC:HBRM) is a botanical therapeutics® company that addresses dermatological and other health and wellness concerns via its proprietary medicinal products that are supported by science-centered content.
In an exclusive interview with the Capital Gains Report, HBRM CEO Dr. Agnes Olszewski discussed the company’s track to take advantage of promising opportunities arising in the natural segment of the wellness industry, particularly as it applies to skincare, and an important boost to this area of the market can get from the application of artificial intelligence.
HBRM’s Approach of Integrating Medicine and Beauty
The global natural cosmetics market is growing at a fast pace and is projected to reach $79.6 billion by 2033, with an annual growth rate of 5.1%. This rise is driven by the emergence of a new category of advanced, natural ingredient-based products available via conventional retail channels and online retailers, as well as the growing prominence of safer and more efficacious science-based beauty and wellness culture, which fuels the accelerated demand for natural beauty products.
Dr. Olszewski said, “One of the most important trends in the healthcare and beauty sectors is the merger of clinical skincare with natural skincare to create safe and validated “hybrid” products that actually work while maintaining their natural ingredient profile.”
Herborium’s acne treatment represents such a unique product. AcnEase is a systemic, all botanical ingredient-based, proprietary, clinically tested acne treatment for teen and adult acne, that also improves symptoms of an inflammatory skin condition called rosacea.
Dr. Olszewski said, “We are presently working on the second generation of this clinically validated skincare solution that has better consumer characteristics -- broader application and simpler treatment routine -- and improved business profile, such as increased margins. The company is also approaching the most advanced science in clinical skincare - stem cell-based products. We are working to add two highly innovative products in this category to our 2023 and 2024 product portfolios.”
The company pursues a cross-sectoral approach, aiming to use clinical testing in order to integrate pharmaceutical and nutraceutical market segments.
Exploring the Power of Artificial Intelligence in Natural Skincare Sector
Another strength of HBRM has to do with the use of pioneering technology as applied to the development of natural skincare products and a total solution that would address consumer concerns in the skincare sector. On May 11, 2023, the company announced signing a Letter of Intent with Adrecom, a US-based technology and e-commerce company with offices in North Carolina and California, to purchase and further advance AI technology that will power HBRM's natural skin health and wellness platform. It completed the first stage of designing this platform and is currently in the midst of testing and further advancing it.
Dr. Olszewski says, “Herborium’s unique approach is the active use of technology in the natural segment of skincare and skin wellness.” The AI platform will deliver streamlined and more precise diagnosis, curated, personalized skincare counseling, products, and other related services such as nutrition and esthetician-provided recommendations.
This step positions HBRM as a frontrunner in the novel skincare industry, opening up new ways for innovation and potential revenue streams. “Our AI-based platform offers an integrated, personalized approach to skincare and skin health,” says Dr. Olszewski. “At the moment, an integrated platform for natural skincare and skin wellness does not exist.”
As medicine and wellness develop in parallel with advancements in using AI technology to support a personalized approach to treatments and more common wellness and beauty solutions, HBRM is a first mover in this space as it is capable of combining its natural ingredient-based products and relevant, cutting edge content with advanced AI technology.
Growth through Partnerships
HBRM is currently commercializing its products and has already established a strong presence in the United States, the United Kingdom, and continental Europe through a network of specialty retailers, distributors, and e-commerce platforms.
With a well-established customer base and strong brand recognition, the company plans to establish new sales targets by building curated partnerships with other product originators. “We are presently in advanced talks with two companies—one from the US and a second from South Korea that are well known in the cosmetic and skin wellness industry for high-quality biotechnological applications in skincare,” says Dr. Olszewski.
Conclusion
Natural ingredients and the potential for an AI-driven personalized approach to skincare mean that Herborium’s products have the potential to gain popularity with consumers quickly. They are capable of connecting medical and beauty applications with a focus on natural ingredients, filling an important gap in the market.
Disclaimers: CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) has been retained by Herborium to assist in the production and distribution of content. 'CGR' is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR is not a fiduciary by virtue of any persons use of or access to this content.
Contact Details
Mark McKelvie
+1 585-301-7700
markrmckelvie@gmail.com
Company Website
http://Capitalgainsreport.com
BRIEF-Tupperware Brands Expects To File Its Form 10-K By Mid-July
As previously disclosed on its Current Report on Form 8-K dated May 8, 2023, the Company engaged Moelis & Company LLC (“Moelis”) to run a
process to explore strategic alternatives, and both Moelis and a Chief Restructuring Officer to advise on potential means to improve the Company’s liquidity and capital structure and other strategic transactions. The process is underway and ongoing; however, there can be no assurance such process or advice will lead to a transaction or improvement in the Company’s liquidity or capital structure.
Time for a strong rebound:
May 30, 2023 1.0500
May 01, 2023 1.3300
Apr 01, 2023 2.5400
Mar 01, 2023 3.9200
Feb 01, 2023 4.7400
Jan 01, 2023 4.9500
Dec 01, 2022 4.8200
Nov 01, 2022 8.0000
Oct 01, 2022 7.7900
Sep 01, 2022 11.7400
Aug 01, 2022 12.8600
BRIEF-Tupperware Brands Expects To File Its Form 10-K By Mid-July
As previously disclosed on its Current Report on Form 8-K dated May 8, 2023, the Company engaged Moelis & Company LLC (“Moelis”) to run a
process to explore strategic alternatives, and both Moelis and a Chief Restructuring Officer to advise on potential means to improve the Company’s liquidity and capital structure and other strategic transactions. The process is underway and ongoing; however, there can be no assurance such process or advice will lead to a transaction or improvement in the Company’s liquidity or capital structure.
Time for a strong rebound:
May 30, 2023 1.0500
May 01, 2023 1.3300
Apr 01, 2023 2.5400
Mar 01, 2023 3.9200
Feb 01, 2023 4.7400
Jan 01, 2023 4.9500
Dec 01, 2022 4.8200
Nov 01, 2022 8.0000
Oct 01, 2022 7.7900
Sep 01, 2022 11.7400
Aug 01, 2022 12.8600
RESHAPE LIFESCIENCES (RSLS) : 2.70
52w: 2.21 – 52,5
Shares Outstanding : 2.94M
Float : 2.54M
Book Value Per Share (mrq) 7.05
Cash and Cash Equivalents as of March 31, 2023, were $9.1 million and the company remains debt free on its balance sheet
“In 2023, we have continued to leverage operational efficiencies, optimize our lead generation programs, and invest in our growth drivers. Our achievement of a 42.9% reduction in operating expenses, excluding one-time charges, during the first quarter, as compared to the same period last year, is a direct result of the execution of our growth pillars. We will continue to drive revenue by expanding our product offering to treat obesity and metabolic disease across the entire care continuum and strengthen our position to exceed our goals,” stated Paul F. Hickey, President and Chief Executive Officer of ReShape Lifesciences®. “We remain focused, not only on growth, but also our future profitability and delivering predictable shareholder value. Our balance sheet was bolstered by two capital raises this year, totaling $12.7 million in gross proceeds. These funds will allow us the continued ability to generate awareness of our evidence-based and differentiated product portfolio that spans the entire care continuum.”
MATTHEW NACHTRAB REPORTS 27.7% STAKE IN RESHAPE LIFESCIENCES AS
NACHTRAB-PURCHASED CO'S COMMON STOCK BASED ON BELIEF THAT SUCH SECURITIES, AT CURRENT MARKET PRICES, REPRESENTED AN ATTRACTIVE INVESTMENT OPPORTUNITY
NACHTRAB - WROTE A LETTER TO THE CEO OF CO WITH RECOMMENDATIONS FOR THE MANAGEMENT TEAM’S STRATEGY GOING FORWARD
I am excited for your new tenure as CEO of ReShape Lifesciences and I believe your team can rebuild and create a $100m plus market cap company with some austerity measures, leveraging assets currently owned, and capitalizing on the medicated weight loss secular trend to generate lead flow and massive revenue growth. I am willing to discuss this and advise in any way I can help.
Time for a strong rebound:
Feb 03, 2023 13.1400 22.4000 11.5600 17.0400 17.0400 11,599,000
Jan 03, 2023 9.6600 20.6300 9.4500 15.6600 15.6600 12,363,900
RESHAPE LIFESCIENCES (RSLS) : 2.70
52w: 2.21 – 52,5
Shares Outstanding : 2.94M
Float : 2.54M
Book Value Per Share (mrq) 7.05
Cash and Cash Equivalents as of March 31, 2023, were $9.1 million and the company remains debt free on its balance sheet
“In 2023, we have continued to leverage operational efficiencies, optimize our lead generation programs, and invest in our growth drivers. Our achievement of a 42.9% reduction in operating expenses, excluding one-time charges, during the first quarter, as compared to the same period last year, is a direct result of the execution of our growth pillars. We will continue to drive revenue by expanding our product offering to treat obesity and metabolic disease across the entire care continuum and strengthen our position to exceed our goals,” stated Paul F. Hickey, President and Chief Executive Officer of ReShape Lifesciences®. “We remain focused, not only on growth, but also our future profitability and delivering predictable shareholder value. Our balance sheet was bolstered by two capital raises this year, totaling $12.7 million in gross proceeds. These funds will allow us the continued ability to generate awareness of our evidence-based and differentiated product portfolio that spans the entire care continuum.”
MATTHEW NACHTRAB REPORTS 27.7% STAKE IN RESHAPE LIFESCIENCES AS
NACHTRAB-PURCHASED CO'S COMMON STOCK BASED ON BELIEF THAT SUCH SECURITIES, AT CURRENT MARKET PRICES, REPRESENTED AN ATTRACTIVE INVESTMENT OPPORTUNITY
NACHTRAB - WROTE A LETTER TO THE CEO OF CO WITH RECOMMENDATIONS FOR THE MANAGEMENT TEAM’S STRATEGY GOING FORWARD
I am excited for your new tenure as CEO of ReShape Lifesciences and I believe your team can rebuild and create a $100m plus market cap company with some austerity measures, leveraging assets currently owned, and capitalizing on the medicated weight loss secular trend to generate lead flow and massive revenue growth. I am willing to discuss this and advise in any way I can help.
Time for a strong rebound:
Feb 03, 2023 13.1400 22.4000 11.5600 17.0400 17.0400 11,599,000
Jan 03, 2023 9.6600 20.6300 9.4500 15.6600 15.6600 12,363,900
AZERION GROUP : 1.52
NL00150006Z9
52w: 1.28 – 9.20
Revenue went from 308 (2021) to 423 (2022)
Latest news:
https://www.azerion.com/azerion-claims-second-spot-as-frances-premier-exclusive-advertising-network/
https://www.azerion.com/azerions-q1-2023-wrap-up/
Azerion Group BV, formerly known as European FinTech IPO Co 1 BV, is a software publishing company based in the Netherlands. The Company is principally engaged in delivering digital entertainment and media platform for media buyers and sellers. The Company operates through Platform and Premium Games segments. Platform segment includes casual games distribution, advertising and e-commerce, which are integrated through its technology. Platform is also integrated with its Premium Games segment. Premium Games include nine game titles of card games and metaverse. Azerion Holding B.V. is the Company’s main operational holding subsidiary. The Company owns several subsidiaries in Germany and France, among others.
AZERION GROUP : 1.52
NL00150006Z9
52w: 1.28 – 9.20
Revenue went from 308 (2021) to 423 (2022)
Latest news:
https://www.azerion.com/azerion-claims-second-spot-as-frances-premier-exclusive-advertising-network/
https://www.azerion.com/azerions-q1-2023-wrap-up/
Azerion Group BV, formerly known as European FinTech IPO Co 1 BV, is a software publishing company based in the Netherlands. The Company is principally engaged in delivering digital entertainment and media platform for media buyers and sellers. The Company operates through Platform and Premium Games segments. Platform segment includes casual games distribution, advertising and e-commerce, which are integrated through its technology. Platform is also integrated with its Premium Games segment. Premium Games include nine game titles of card games and metaverse. Azerion Holding B.V. is the Company’s main operational holding subsidiary. The Company owns several subsidiaries in Germany and France, among others.
1 dollar today??
NVFY: 0,7388 + 53.92%
Nova LifeStyle, Inc., through its subsidiaries, designs, manufactures, markets, and sells residential and commercial furniture for middle and upper middle-income consumers worldwide. The company offers upholstered, wood, and metal-based furniture pieces for the living, dining, and bedrooms, as well as home offices. Its products include sofas, chairs, dining and coffee tables, beds, entertainment consoles, cabinets, and cupboards. The company also provides physiotherapeutic jade mats for use in therapy clinic, hospitality, and real estate projects. It distributes its products under the Diamond Sofa brand directly, as well as through internet sales and online marketing campaigns, and participation in exhibitions and trade shows primarily to furniture distributors and retailers. The company was formerly known as Stevens Resources, Inc. Nova LifeStyle, Inc. was founded in 2003 and is headquartered in Commerce, California.
https://novalifestyle.com/
Feb 01, 2023 0.9300 1.3700 0.6700 0.7500 0.7500 1,080,000
Jul 31, 2022 0.7400 1.3400 0.7000 0.7500 0.7500 6,661,300
Mar 01, 2021 3.0100 7.4900 2.0400 3.2400 3.2400 45,086,500
1 dollar today??
NVFY: 0,7388 + 53.92%
Nova LifeStyle, Inc., through its subsidiaries, designs, manufactures, markets, and sells residential and commercial furniture for middle and upper middle-income consumers worldwide. The company offers upholstered, wood, and metal-based furniture pieces for the living, dining, and bedrooms, as well as home offices. Its products include sofas, chairs, dining and coffee tables, beds, entertainment consoles, cabinets, and cupboards. The company also provides physiotherapeutic jade mats for use in therapy clinic, hospitality, and real estate projects. It distributes its products under the Diamond Sofa brand directly, as well as through internet sales and online marketing campaigns, and participation in exhibitions and trade shows primarily to furniture distributors and retailers. The company was formerly known as Stevens Resources, Inc. Nova LifeStyle, Inc. was founded in 2003 and is headquartered in Commerce, California.
https://novalifestyle.com/
Feb 01, 2023 0.9300 1.3700 0.6700 0.7500 0.7500 1,080,000
Jul 31, 2022 0.7400 1.3400 0.7000 0.7500 0.7500 6,661,300
Mar 01, 2021 3.0100 7.4900 2.0400 3.2400 3.2400 45,086,500
NOVA LIFESTYLE INC (NVFY) 0,5616 +17,00%
Nova LifeStyle, Inc., through its subsidiaries, designs, manufactures, markets, and sells residential and commercial furniture for middle and upper middle-income consumers worldwide. The company offers upholstered, wood, and metal-based furniture pieces for the living, dining, and bedrooms, as well as home offices. Its products include sofas, chairs, dining and coffee tables, beds, entertainment consoles, cabinets, and cupboards. The company also provides physiotherapeutic jade mats for use in therapy clinic, hospitality, and real estate projects. It distributes its products under the Diamond Sofa brand directly, as well as through internet sales and online marketing campaigns, and participation in exhibitions and trade shows primarily to furniture distributors and retailers. The company was formerly known as Stevens Resources, Inc. Nova LifeStyle, Inc. was founded in 2003 and is headquartered in Commerce, California.
https://novalifestyle.com/
Shares Outstanding 6.95M
Float 4.17M
Book Value Per Share (mrq) 0.75
May 01, 2023 0.5400 0.6100 0.4800 0.4800 0.4800 76,700
Apr 01, 2023 0.6100 0.7200 0.5500 0.5500 0.5500 145,500
Mar 01, 2023 0.6700 0.7600 0.5100 0.6000 0.6000 134,600
Feb 01, 2023 0.9300 1.3700 0.6700 0.7500 0.7500 1,080,000
Jan 01, 2023 0.4600 0.9000 0.4400 0.8500 0.8500 472,700
Dec 01, 2022 0.5300 0.5900 0.3900 0.4300 0.4300 423,200
Oct 31, 2022 0.6100 0.6800 0.4700 0.5100 0.5100 303,100
Sep 30, 2022 0.7200 0.8100 0.5900 0.6000 0.6000 286,200
Aug 31, 2022 0.7600 0.8100 0.6800 0.7400 0.7400 474,900
Jul 31, 2022 0.7400 1.3400 0.7000 0.7500 0.7500 6,661,300
Jun 30, 2022 0.7600 0.8100 0.6800 0.7400 0.7400 252,900
May 31, 2022 0.7800 1.0300 0.6300 0.7200 0.7200 1,298,900
Apr 30, 2022 1.0700 1.1800 0.6300 0.7800 0.7800 625,200
Mar 31, 2022 1.5000 1.7900 1.0300 1.0600 1.0600 834,400
Mar 01, 2022 1.2900 1.5600 1.1400 1.5000 1.5000 1,246,800
Feb 01, 2022 1.5500 1.7900 1.2500 1.3200 1.3200 1,674,100
Jan 01, 2022 1.8600 1.9900 1.4700 1.6000 1.6000 1,167,400
Dec 01, 2021 1.9800 2.0800 1.7700 1.8700 1.8700 1,115,600
Oct 31, 2021 2.2800 2.4800 1.8700 1.9500 1.9500 1,774,900
Sep 30, 2021 2.2800 2.7100 2.1000 2.2700 2.2700 4,279,100
Aug 31, 2021 2.3300 2.4600 2.0800 2.2700 2.2700 3,544,800
Jul 31, 2021 2.2800 2.6000 1.9000 2.3700 2.3700 5,851,200
Jun 30, 2021 3.1400 6.6600 2.1000 2.2800 2.2800 56,231,500
May 31, 2021 3.0000 3.4100 2.7700 3.1400 3.1400 899,200
Apr 30, 2021 2.8100 3.5900 2.5200 2.9900 2.9900 1,329,900
Mar 31, 2021 3.3500 3.4400 2.6100 2.7300 2.7300 734,000
Mar 01, 2021 3.0100 7.4900 2.0400 3.2400 3.2400 45,086,500